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Resistance towards antimicrobial agents is an increasing medical problem nowadays caused by 
the elimination of susceptible bacteria leaving only the resistant ones to survive and evolve. 
Evolution through mutations that lead to antibiotic resistance in bacteria increases the diversity 
of bacterial genomes. Under antibiotic treatment, these mutations might be advantageous for 
the bacteria, but disadvantage in the absence of antibiotic due to fitness cost. By understanding, 
how mutations can have an impact on the fitness cost for individual resistance determinants and 
the interactions that occur within one genetic background can foster our understanding of 
epistasis. The importance of understanding epistatic interactions between genetic determinants 
that are responsible for a resistant phenotype can be essential in the treatment of bacterial 
infections with antimicrobial drugs.  
In this study, mutants of clinical Escherichia coli strains with reduced susceptibility towards 
trimethoprim and/or ciprofloxacin were generated to test whether epistatic interactions in 
certain combinations of mutants existed. Growth curve measurements were used to calculate 
the relative generation time as a measure of fitness. The result revealed that the generation time 
of double mutant TP+CIP22 was reduced with 7 minutes compared to the single mutant TP22, 
resulting in a potentially positive epistatic interaction. However, a negative epistatic interaction 
may have occurred due to a decrease in minimal inhibitory concentration (MIC) determined for 
trimethoprim in all double mutants (TP+CIP) compared to the respective single mutants (TP). 
The results provided here promote our understanding of epistatic interactions in bacteria. 
Hopefully, together with findings of further experiments, they will be implemented in 
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1  INTRODUCTION 
 
1.1 Preface 
Bacteria adapt to changing environmental conditions during the process of evolution. Thus, 
they bear the potential to become a big threat to man-kind in the future due to the increased 
consumptions of antibiotics and the rapid development of bacterial resistance to antibiotics 
(Goossens et al., 2005). Antimicrobial agents are either produced by other organisms (penicillin 
G), through chemical modifications of existing scaffolds (EX), or completely synthetic 
(ciprofloxacin). When bacteria become resistant to a certain antibiotic, they in turn might 
become less fit compared to its susceptible counterpart when the antibiotic is not present 
(Andersson and Levin, 1999). Bacteria can become resistant through mutations in the genome 
or by receiving genetic material (encoding resistance determinants) from other organisms 
during horizontal gene transfer. By having the knowledge about how resistance mechanisms 
work in bacteria, it is therefore possible to use that knowledge to fight the rapid development 
of antibiotic resistance. In this study, we generated reduced susceptibility in Escherichia coli 
(E. coli) strains to given antimicrobial agents through spontaneous mutations and subsequently 
aimed to identify epistatic interactions between the different resistance determinants. We 
propose that if such general patterns exist in bacterial populations we can through innovative 
antibioitic stewardship “force” bacterial evolution along the least favorable path that may 
optimize reversal of resistance.  
  
1.2 Antimicrobial agents 
Alexander Fleming’s discovery of Penicillin in the 1930’s is regarded as one of the major 
breakthroughs in medicine. Since then, the discovery of new, innovative antimicrobial agents 
gave the world an opportunity to fight against infectious diseases caused by bacterial pathogens. 
The antimicrobial agents can be categorized in either bacteriostatic or bactericidal, depending 
on their effect on the bacteria: bacteriostatic antibiotics slow down the growth of bacteria by 
interfering with vital processes like protein synthesis. However, bactericidal antibiotics kill 
bacteria, for example by interrupting cell wall synthesis (Pankey and Sabath, 2004). Antibiotics 
can also be classified into broad spectrum antibiotics, which affect a variety of bacteria, or 
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narrow spectrum antibiotics that are only affecting a smaller range of bacteria (Leekha et al., 
2011). Trimethoprim and Ciprofloxacin are the two antibiotics that were used in this study and 
are described below. 
 
Trimethoprim is a bacteriostatic antibiotic and acts by inhibiting the folic acid synthesis in 
bacteria, which is necessary for the DNA (deoxyribonucleotide acid) synthesis. The drug 
competes with dihydrofolic acid for the enzyme dihydrofolate reductase (DHFR), which 
usually transforms its substrate into tetrahydrofolic acid, but not in the presence of trimethoprim 
(competitive inhibition, see Figure 1) (Quinlivan et al., 2000). In the treatment of urinary tract 
infection in Norway, it is common to combine trimethoprim with sulphonamide antibiotic 
sulfamethoxazol for a treatment duration of 3 days. Sulfamethoxazol also acts as a competitive 
inhibitor by interfering the p-aminobenzoic acid (PABA) and dihydrofolate diphosphate for the 
binding of dihydrofolate reductase enzyme from preventing the synthesis of folate (Rang et al., 
2007). Fortunately, the inhibition of folic acid synthesis in bacteria does not affect folic acid 
synthesis in human, because they tend to get it through external sources like food supplements. 
Trimethoprim has also a much higher affinity for bacterial DHFR, making trimethoprim a drug 
with antimicrobial target specificity.  
 
 
Figure 1: Overview of trimethoprim’s site of action by inhibiting the dihydrofolate reductase 
enzyme from synthesizing the essential folic acid in bacteria. 
 
In a study of Flensburg and Sköld, resistance of clinical E. coli isolates against trimethoprim 





and Sköld, 1987). However, newer study showed resistance towards trimethoprim had occurred 
in the efflux pump expressed by the BpeEF-OprC gene, and also mutations in DHFR could 
cause resistance to trimethoprim (Podnecky et al., 2013). 
 
Ciprofloxacin belongs to the second generation of the fluoroquinolone class of antibiotics. It 
has a bactericidal effect by targeting DNA gyrase and topoisomerase IV, enzymes that are 
important for the negative supercoiling of double stranded DNA (dsDNA), and kills the bacteria 
by preventing DNA replication (Hooper, 1999, Yoshida et al., 1990). A study on 
fluoroquinolone resistance in 54 E. coli urinary tract infection (UTI) clinical isolates from 
Sweden showed that resistance towards ciprofloxacin in E. coli is associated with mutations in 
the gyrA gene. However, mutations in genes such as gyrB, parC, pare, marOR and  acrR also 
played a role in the emergence of resistance to fluoroquinolones (Komp Lindgren et al., 2003). 
Spontaneous mutations in gyrA or gyrB are associated with quinolone resistance E. coli because 
DNA gyrase is encoded by the gyrA and gyrB genes (Yoshida et al., 1990). However, the 
majority of quinolone resistance in clinical E. coli isolates is caused by mutations in the gyrA 
gene (Pourahmad Jaktaji and Mohiti, 2010). 
Both trimethoprim and ciprofloxacin are antibiotics that are implemented in the treatment of 
urinary tract infections in Norway, an infection that is most commonly caused by the Gram-
negative bacteria E .coli.  
 
1.2.1 Antibiotic targets 
As mentioned above, antibiotics are classified as being bacteriostatic or bactericidal or 
alternatively narrow-spectrum or broad-spectrum antibiotics. They exhibit different targets 
within bacteria. The three major modes of action are: inhibition of cell wall synthesis, inhibition 
of DNA/RNA synthesis and inhibition of protein synthesis.  
Cell wall synthesis: the structure of a bacterium’s cell wall differs from whether if it is a Gram-
negative bacterium or a Gram-positive bacterium. Cell wall synthesis is inhibited by the 
antibiotic agent interfering with important processes during synthesis of the peptidoglycan 
layer. Classes of antibacterial drugs that interferes with the cell wall synthesis are beta lactams, 
lipopeptides, glucopeptides and glycolipopeptides, reviewed in (Kohanski et al., 2010).  
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DNA/RNA synthesis: ciprofloxacin and trimethoprim (see 1.2 for their site of action) are 
antibiotics that are known to either i) inhibit the replication of DNA strands in bacteria 
(ciprofloxacin) or ii) competitively inhibit enzymes that are important for the synthesis of DNA 
precursor molecules (trimethoprim). Rifamycins are a class of antimicrobial drugs that inhibit 
the synthesis of RNA, reviewed in (Kohanski et al., 2010). 
Protein synthesis: aminoglycosides, tetracyclines and macrolides inhibit protein synthesis in 
bacteria through a variety of mechanisms. Generally, their binding to the 30S or 50S ribosomal 
subunit prevents bacterial proteins synthesis, reviewed in (Kohanski et al., 2010).  
 
1.3 The development of resistance to antimicrobial agents 
Antimicrobial drugs are one of many drugs in the world that lose their effect on bacteria, as 
they are frequently over- and misused, which leads to the emergence of resistant microbes. The 
drugs we use to fight against nasty infections caused by pathogenic bacteria are either from 
chemically synthesized or occur naturally. Over the course of the 20th century, the discovery of 
antimicrobial agents has made dangerous infectious diseases easily treatable (Davies and 
Davies, 2010). However, today, the rate of development of antimicrobial drug resistance has 
increased significantly over the last two decades making this a worldwide medical problem 
(Wright, 2010, Wright, 2013). Resistance to antimicrobial drugs in the medical world is defined 
as: “organisms that will not be inhibited or killed by an antibacterial agent” (Mims et al., 2008). 
The problem lies therefore in the continuous evolution of bacteria and their adaption to the 
existing antibiotic agents. Using antimicrobial drugs forces the bacteria into a selective pressure 
by killing or growth inhibition of susceptible bacteria. The development and spread of 
resistance to antibacterial agents occurs in several ways, however, in this thesis I will describe 
two main processes: 1) by receiving a resistant gene through horizontal gene transfer or 2) by 







1.3.1 Horizontal gene transfer  
As bacteria exposed to an antibiotic for which they are susceptible for will die, resistant ones 
increase in number due to profitable spatial and nutritional conditions for survival and also by 
sharing their resistance determinants with other bacteria through mechanisms such as horizontal 
gene transfer (HGT)(Jain et al., 1999). Mechanisms of HGT in prokaryotic cells include the 
uptake of foreign DNA and subsequent incorporation into the recipients’ own genome. 
Expression of the newly acquired DNA may, at best, lead to a beneficial phenotypic trait, such 
as resistance to antibiotics.  The transfer can occur between different bacterial species. There 
are many ideas about why HGT occurs, this is however not the topic of the thesis. A major 
consequence of HGT is the spread of adaptive traits such as antibiotic resistance genes between 
bacteria (Koonin et al., 2001). The three mechanisms by which bacteria can obtain foreign DNA 
are termed transformation, transduction and conjugation. However, there was a recent study 
that stated a fourth mechanism of HGT: Outer membrane vesicles (Fulsundar et al., 2014). 
 
1.3.1.1 Transformation 
Transformation occurs when a bacterial cell takes up foreign DNA from its environment by 
actively bringing that DNA across its plasma membrane eventually integrating it into the 
genome (Thomas and Nielsen, 2005). A competent (recipient) cell takes up the foreign DNA 
from its environment and the DNA is then integrated into the genome through recombination 
(Redfield, 1988). Only a small fraction of the bacteria species, ca 60 species are naturally 
competent, reviewed in (Johnsborg et al., 2007). The first discovery of a natural competent 






Bacterial viruses/bacteriophages mediate transduction by attaching themselves to bacterial cells 
and inject their genetic material into the cytoplasm of the recipient bacterium, reviewed in 
(Frost et al., 2005). Bacteriophages (donor) use the recipient bacteria as their host to generate 
new phage particles by incorporating the phage DNA into the recipients’ DNA (Koonin et al.).  
The virus is then dependent on the host bacteria for the replication of new phage particles. The 
new phage particles emerge from their host; some may carry pieces of bacterial DNA. If the 
new bacteriophages attach to other bacteria and the DNA becomes incorporated into the 
recipient genome, new genotypes of bacteria arise (Frost et al., 2005).  
 
1.3.1.3 Conjugation 
Conjugation is a common mechanism for spread of antibiotic resistance determinants and 
involves the transfer of genetic information through cell-to-cell contact. The transmission of 
genetic elements like plasmid-DNA occurs between a donor cell and a recipient cell. The 
genetic material could either be a copy of a plasmid or other elements like transposons 
associated to a conjugative function, reviewed in (Brown-Jaque et al., 2015). These elements 
are known to be mobile genetic elements that can implement the transfer of DNA between 
bacterial cells. The transmission takes place after the bacterial cell grows a duct (pilus) and 
attaches it to the other bacterium. Conjugative elements such as plasmids traverse the cell wall 
and plasma membrane through pores connecting donor and recipient (Chen et al., 2005).  
 
1.3.2 Mutations 
Mutations, also known as de novo genetic changes (Low et al., 1999), are changes that occur 
randomly in the DNA sequence and can either be neutral, harmful or advantageous for the 
bacterium (Sniegowski et al., 1997). This kind of changes give the organism an opportunity to 
generate genetic diversity allowing the change to be beneficial for further evolution by having 
the chance to adapt and survive better in the environment (Metzgar and Wills, 2000).  Most 
mutations that happens naturally are rather deleterious for the organism than beneficial. 
However, some of the mutations can be beneficial for the bacterium, for instance, rendering it 





1.3.2.1 Chromosomal-mediated resistance  
Chromosomal-mediated resistance are mutations that occurs through spontaneous mutations 
enriched during antibiotic exposure of bacteria. Mutations in different sites in the chromosome 
can result in different types of resistance mechanisms depending on the species of the bacterium 
and the antimicrobial agent used. For example, a mutation that lead to an increased or decreased 
synthesis of an altered protein that can supress the effect of an antibiotic agent (Mims et al., 
2008).  
 
1.4 The fitness cost of antimicrobial resistance and compensatory adaptation 
Fitness is described as “the capability of a genotype or individual to survive and reproduce” 
(Andersson and Hughes, 2010) and therefore determines its evolution. It is assumed that a 
mutant bacterial strain is less fit compared to its respective wild type (Andersson and Levin, 
1999). Even though bacteria have the capability and developed resistance to all currently 
employed class of antimicrobial agents, the cost for having the resistance gene can be high for 
the resistant bacteria, particularly immediately after the acquistion (Schrag et al., 1997, 
Starikova et al., 2013). Consequently, the resistant strain is prone to be outcompeted by other 
sensitive strains if the environment is representative for the susceptible bacteria. That may result 
in a slower growth in the resistant strain compared to the sensitive strain (Low et al., 1999). 
There are studies that show a reduction in fitness when carrying a resistance trait obtained either 
by a plasmid transfer or by a mutation (Starikova et al., 2013, Starikova et al., 2012, Johnsen et 
al., 2002). The reason why antimicrobial resistance determinants are often costly for the bacteria 
is due to the possible negative effects of mutation, like the extra burden of synthetizing a protein 
that leads  to microbial resistance to a certain antibiotic (Zu and Lebek, 1980, Jin and Gross, 
1989).  
Fitness can be measured in absolute fitness and relative fitness. Absolute fitness defines the 
absolute growth of the resistant strain and the growth of the wild type strain whilst relative 
fitness is the ratio measured from the absolute fitness of the resistant strain and the ancestral 




Compensatory adaptations describes mutational changes within or outside a resistance 
determinant that increases the resistant bacterial relative fitness without loss of the resistant 
phenotype. Through a second mutation, the initial biological fitness cost of resistance 
expression (usually engendered in the absence of antibiotic selection pressure) will decrease 
without loss of resistance (Normark and Normark, 2002). Another example would be, if a wild 
type organism undergoes detrimental mutational changes, that mutation will most likely lower 
the fitness of that organism (Andersson and Levin, 1999). However, one additional mutation 
could have the effect of increasing the organisms’ fitness (Björkholm et al., 2001). This will 
help the organism to compensate a detrimental mutation. It is possible to have more than one 
compensatory mutation; in fact, multiple compensatory mutations can slowly build up the 
fitness back to where it was (Andersson, 2006). As mentioned above, compensatory adaptations 







1.5 Reversal of antimicrobial drug resistance 
To a certain extend, the reversal of antimicrobial drug resistance in bacteria is possible when 
the antimicrobial drug is removed. This is due to the fitness decrease in resistant bacteria: in an 
antibiotic free environment susceptible bacteria outcompete the resistant ones (Andersson and 
Levin, 1999). However, there has been a study showing that the withdrawal of the antimicrobial 
agent did not decrease the resistant frequency among E. coli  (Enne et al., 2001). In Figure 2, 
Johnsen and his team has made an illustration on how the reversal of antimicrobial drug 
resistance occurs (Johnsen et al., 2009).    
  
Figure 2: Overview of the reversal of antimicrobial drug resistance. This figure shows that the 
frequency of resistance is high when the antibiotic is present, however, when the drug is removed, 
a selective pressure occurs among the resistant bacteria making the frequency of resistance drop 
significantly due to reduced fitness cost (A) when the compensatory evolution is not present. In case 
(B), the presence of compensatory evolution is making the bacteria more fit, the reversal of 
antimicrobial drug resistance is taking much longer time compared to case (A). Other factors may 
play a part in preventing the resistance frequency to decrease through linked selection, stability of 
resistance or/and acquisition and transfer as shown in case (C). However, if the antibiotic is 
reintroduced (D), the frequency of resistance in bacteria will immediately go back to where it was 
in the beginning. (Adopted and modified from (Johnsen et al., 2009)).  
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1.6 Epistatic interactions between determinants of antibiotic resistance  
The term epistasis was first mentioned by a biologist, William Bateson, over 100 years ago, 
reviewed in (Phillips, 2008). Epistasis is a way for bacteria to develop genetic diversity through 
genetic interactions that determine the bacterial phenotype (Cordell, 2002). In addition, 
epistasis play a big part in the evolution of developing resistance towards antimicrobial agents. 
In our study, epistasis can be explained by Figure 3.  
  
Figure 3: Illustration of an epistatic interaction between determinants of antibiotic 
resistance. Susceptible E. coli strain developing resistance towards three antibiotic agents. 
For each gene interaction occurring after resistance acquisition, there will either be a 
positive epistatic effect (+ Epistasis) or a negative epistatic effect (- Epistasis). The expected 
theoretical outcome is shown as a dashed “empty” box. The more resistance traits (XR) E. 
coli accumulates during time for different antibiotic agents, the less fit the bacteria become. 
Positive epistasis is represented when the fitness of the bacteria suddenly gets significantly 
higher than the previous starting point and the reversal of resistance (graph shown to the 
left) would decrease, and takes much longer time. The opposite happens through negative 
epistasis when the fitness of the bacteria is reduced significantly after the development of 
resistance to a third antibiotic agent, however, the reversal of resistance would decrease 






The term epistasis can be very complex to interpret. Epistasis describes the biological concept 
of gene interactions in organisms. By understanding epistatic interactions, it may be possible to 
map a pattern of antimicrobial resistance development/evolution, triggered either by mutations 
or by mobile genetic elements (MGE) for clinical use (our study). From clinical point of view, 
if epistatic interactions can be predicted it could allow us to propose optimized temporal 
consumption patterns that could in theory “force” microbial evolution along the least favourable 
evolutionary path. In our study, epistasis can be defined in terms of magnitude epistasis and 
sign epistasis.  
Magnitude epistasis can be defined as synergistic or antagonistic. The effect of synergistic 
(positive epistasis) interactions from a relative fitness perspective mean that the net effect of 
two or more resistance determinants in the same genetic background is lower than if they were 
in individual cells, reviewed in (zur Wiesch et al., 2011). The opposite effect is seen in 
antagonistic (negative epistasis) where the combined effect of two or more detrimental 
mutations on fitness are higher than if present in single genetic backgrounds (Khan et al., 2011) 
(see Figure 3 for illustration).  
Sign epistasis happens in the presence of a single mutation, that can have either a beneficial or 
a deleterious effect, and a second mutation which is present depending on a certain genetic 
background of the bacteria (Trindade et al., 2009). A study showed that when a bacterial strain 
carried a chromosomal mutation together with a resistant plasmid, this strain was much fitter 
compared with its respective resistance determinants (Silva et al., 2011). They also found out 
that epistasis that occurs naturally is not gene specific, but rather allele specific. Compensatory 
adaptation is an example of sign epistasis (see 1.4).  
In theory, the fitness cost of bacterial mutations in the genome can be combined additively (as 
illustrated in Figure 3). For instance, an additive effect is identified when two mutations 
describe a sum that was added up based on single mutations. The additive effect is therefore 




1.7 Aim and objectives   
 
Project idea 
The project idea is to “identify temporal patterns of drug use that maximize the fitness costs of 




Find a way to combine different antimicrobial agents for innovative antimicrobial treatment 




General patterns of negative epistatic interactions exist between certain combinations of 





1. To see if the additive effect of resistant genes has the potential to cause an epistatic 
interaction with single or double mutants.  
2. To determine the fitness of the organism that carries a resistance determinant relative to 








2.1 Bacterial strains 
The strains used in this study, presented in Table 1, were used to generate antibiotic resistance 
mutants and for further fitness competitions assays. Eighty clinical E. coli isolates from the 
ECO-SENS collection (provided by Ørjan Samuelsen, UNN, Tromsø) were immediately frozen 
down as freeze stock cultures. This collection of E. coli isolates ordinated from patients with 
uncomplicated urinary tract infection (UTI). The isolates were collected from four different 
countries in Europe (Sweden, UK, Greece and Portugal). The isolates can be divided into ECO-
SENS 1 or ECO-SENS 2 collections depending on when they were obtained (Kahlmeter, 2000, 
Kahlmeter and Poulsen, 2012). The E. coli isolates were also divided into phylogenetic groups, 
which can be categorize into four main parts: A, B1, B2 and D (Clermont et al., 2000).  
 
Table 1: ECO-SENS strains; clinical E. coli isolates used in this study 
Name of strains Phylogenetic group From  
K56-22 B2 Sweden (1999-2000) ECO-SENS 1  
K56-41 D Greece (2007-08) ECO-SENS 2  




2.2 Growth media  
2.2.1 Sterilization of media and solutions 
All media and solutions used in this study were autoclaved at 121°C for 20 minutes (Certoclav, 
Getinge).  
 
2.2.2 Luria Bertani broth 
Luria-Bertani Broth, Miller (LB) contained 10 g of tryptone, 5 g of yeast extract and 10 g 
sodium chloride per litre of distilled water. LB is the base for the maintenance and propagation 
of E. coli. 20 g of LB powder were dissolved in 800 ml distilled water followed by 
autoclavation. The LB medium was stored at room temperature.  
 
2.2.3 Luria Bertani Agar 
In this study, solid LB was prepared by adding 12 g of Select agar (Sigma-Aldrich, Germany) 
into 800 ml of LB solution. LB agar was autoclaved before use. 800 ml of LB agar resulted in 
approximately 40 plates. 
 
2.2.4 LB agar plates with antibiotic 
For preparations of selective LB agar plates that contained the desired antibiotic concentration, 
antibiotic stock solution was only added into the autoclaved LB agar when the temperature was 
cooled to 50-60°C to prevent destruction of the antibiotics. This applied to all antibiotics that 
were used in this study. Trimethoprim LB agar plates were prepared by adding the necessary 
volume of 100 mg/ml trimethoprim stock solution (provided by Julia Kloos). Trimethoprim 
plates were made in the following concentrations: 4, 8, 16 and 32 µg/ml. Ciprofloxacin LB agar 
plates were made from a 10 mg/mL ciprofloxacin stock solution in the following 
concentrations: 0.1 and 0.25 µg/ml. The concentrations were determined according to the 
minimal inhibitory concentration (MIC) value performed on the three ancestor strains (K56- 






2.3.1 Antibiotic stock solutions  
The antibiotic stock solutions were stored at -20°C when not in use and only thawed 30-60 
minutes before preparation of the LB agar plates. 0.1 g of ciprofloxacin (BioChemika, Sigma-
Aldrich) were mixed with 10 ml of distilled water in a sterile 45 ml falcon tube (BDTM Falcon, 
USA). Mixed the content using a vortex machine, followed by adding 9-10 drops of 
hydrochloric acid (HCl) 3.7% (provided by Ane Utnes) for the ciprofloxacin powder to dissolve 
in the distilled water, resulting in a 10 mg/mL ciprofloxacin stock solution. The solution was 
then sterile filtered through a syringe filter (25 mm, Acrodisc®) directly into a sterile falcon 
tube (10 ml). No pH adjustments were done. The trimethoprim stock solution was provided 
beforehand (100 mg/ml in dimethyl sulfoxide (DMSO), Aldrich, Germany).  
 
2.3.2 Freeze stock solutions 
A freeze stock solution was prepared using LB media amended with 25% glycerol in a Falcon 
freeze tube (VWR International, USA). A sterile, single-use-1µL loop was filled with generous 
amount of selected bacteria and suspended into the freeze stock solutions. To make sure that 
most of the collected bacteria were resuspended, the tubes were vortex before freezing down. 
The strains were frozen down at -75°C for long-term storage and further experiments.   
 
2.3.3 Buffers and other solutions 
Buffers and other solutions that were necessary for this experiment are listed below. Most of 
the solutions and buffers were already made beforehand, and these were most often made from 
a general protocol in the lab to carry out basic methods (Sambrook and Russel, 2001) .  
0.9% NaCl (saline solution) was made by dissolving 9 g sodium chloride (NaCl) (Sigma-




Glycerol 50% was mainly used for the freeze stock solution and was made by dissolving        
57.5 ml of glycerol 86-88% (Sigma-Aldrich, Germany) with 42.5 ml of demineralized water 
giving a total volume of 100 ml. The glycerol was autoclaved and stored at room temperature.  
1xTAE buffer (Tris/acetate/EDTA) was used for gel electrophoresis and preparation of agarose 
gel. 1xTAE was diluted from 50xTAE stock solution with demineralised water. 50xTAE was 
already made beforehand. No autoclavation was needed.  
Loading buffer (6X) is a blue solution used in polymerase chain reaction to keep the DNA 
samples in the bottom of the well and for visualizing how far the DNA sample has gone when 
running the gel electrophoresis.  This blue loading dye was made beforehand. 
 
2.4 M13 Primer 
The primer used in this study was the M13 RAPD-PCR primer (Sigma-Aldrich, Germany). 
According to the manufacturer, the freeze-dried primer was prepared by dissolving it with 
ddH2O (double distilled water) to a concentration of 100 µM before use. The primer was stored 
at -20°C in liquid form. For the experiment, the primer was diluted to a 5 µM solution by mixing 
5 µL of M13 primer (100 µM) with 95 µL ddH2O resulting in a total volume of 100 µL. 
Table 2: An overview over the M13 primer sequence 










3.1 Generation and characterization of antibiotic resistant mutants 
3.1.1 Generation of single resistant mutants 
The most reasonably way to generate mutants resistant to one certain antibiotic, was to expose 
the strains to the antibiotic and whichever strain managed the exposure to the antibiotic would 
most likely grow due to decrease in susceptibility towards the respective antibiotic. These will 
be collected for further characterization.  
The three E. coli strains (K56-22, 41 and 78) that were included for this experiment were 
streaked on sterile LB agar plates directly from the ECO-SENS freezing stock collection and 
incubated for 16-18 hours at 37°C. To prepare an overnight culture (ONC) one single colony 
from the LB plate was used to inoculate 35 mL of LB medium in a sterile 100 ml flask. A 
negative control was incubated containing the same LB (3 mL in sterile glass tube). Both, the 
negative control and the ONC were incubated for 16-18 hours (150 rpm, 37 °C). Incubation 
between of 16-18 hours results in a cell number of approximately 109 cells/ml. 10 ml of the 
ONC was distributed into falcon tubes (volume 45 mL) and the contents were centrifuged at 
4000 rpm for 10 minutes. The pellet that remained in the bottom of the falcon tube was kept 
whereas the supernatant was discarded. 1 mL of fresh liquid LB was used to resuspend the 
pellet, and 100 µL of the pellet solution were plated per LB plate with the required antibiotic 
concentration (in totalt 10 plates/experiment). Trimethoprim 100 mg/mL and ciprofloxacin 10 
mg/mL were used to generate single resistant mutants. All the plates were incubated at 37°C 
until visible colony growth (maximum 3 days of incubation). Approximately ten mutant 





3.1.2 Generation of double resistant mutants 
The generation of double resistant mutants was performed in exactly the same way as the 
generation of single resistant mutants (see 3.1.1). The method included the exposure of those 
mutants, which already carried a resistance mutation for either trimethoprim or ciprofloxacin, 
to the other antibiotic, respectively. In this study, trimethoprim resistant E. coli mutants were 
plated on selective plates containing the desired concentration of ciprofloxacin (as described in 
2.2.4). The generation of double resistant mutants was applied to all three trimethoprim resistant 
E. coli mutant strains (K56- 22, 41 and 78).  
 
3.2 Confirmation of mutants   
To verify the mutant colonies growing on antibiotic LB agar plates as E. coli mutants, ten 
colonies were randomly selected per strain growing on the desired antibiotic LB agar plates. 
Marking the new plates with the same antibiotic concentration into sections, the colonies that 
were selected, were streaked on each given sections together with a wild type strain as a 
negative control (see Figure 4 for illustration) and the plates were incubated for 24 hours at 
37°C. This type of control showed whether the mutants selected for further characterization 
would grow again when the same antibiotic pressure was present. By comparing the mutants’ 
growth with the growth of the wild type strain (no growth expected wild type strain = negative 
control) false mutants could be detected. 
 
3.2.1 Streak methods 
The paper strip method: This method was used to collect small colonies. To ensure that only 
the colony was touched the corner of a sterile paper strip was used to pick a single colony. This 
method was also used to confirm whether or not the selected colonies were mutants by 
















Quadrant Streak Method: This method was often used to streak bacteria from a freeze stock 
on a fresh LB agar plate for further experiments. New streaks were made every week starting 
from the respective freeze stock (see Figure 5).   
  
Figure 5: This figure shows a quadrant streak, which was performed on a LB agar 
plate. The bacterial growth is at its densest on the first (1) streak, however after the 
second (2) and the third streak (3), the less dense the growth will become. On the last 
streak (4), single colonies will most likely appear. 
Figure 4: This illustrates the paper strip method starting with point one (1) 
following the direction of the arrow making one streak and from that streak, 
the second (2) streak follows a zig-zag motion.  
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3.3 Polymerase chain reaction (PCR) 
To confirm all the mutants that were generated for the purpose of E. coli being resistant to the 
antibiotics used in this study, all of the mutants from each strain that were isolated for further 
experiments needed to be confirmed as E. coli before being frozen down. PCR has become the 
most commonly used method to amplify a specific DNA sequence into millions of copies for 
genetic characterizations (Mullis, 1990). The PCR-machine is a programmable heating block 
that alternates between different temperatures in the following three main cycles: 1) 
denaturation of the double stranded DNA into single stranded DNA (ssDNA) at 95 °C. 2) 
annealing step at a temperature can vary from 36-60 °C, allowing the primer to bind to the 
specific complimentary site on the ssDNA for further amplifications, and 3) elongation of the 
ssDNA into dsDNA using a heat-resistant DNA polymerase to attach the four 
deoxyribonnucleotide tri phosphates (dATP, dCTP, dGTP and dTTP) onto the ssDNA strand- 
at 72 °C. The cycles were repeated using the newly created dsDNA as a template for further 
formation of the same DNA sequence, resulting in an exponential generation of the specific 
DNA sequence.  The PCR-reactions were carried out using the RAPD-1 thermocycler program 
shown in Table 3: 
 
Table 3: RAPD1 thermocycler program used in this study 
Step Temperature  Duration 
1 95 °C 5 min 
2 95 °C 1 min 
3 36 °C 1 min 
4 72 °C 2 min 
5 Repeat 2-4 45 times 







3.3.1 Template DNA for PCR 
Each DNA template was prepared by resuspending several single colonies, harvested with a 
sterile 1µl loop in 50 µL of ddH2O (double distilled water). The suspension was mixed using a 
vortex machine.  
 
3.3.2 PCR controls 
Three controls were included in this experiment and are listed in Table 4: 
Table 4: overview over sample controls used in PCR 
Control type Bacteria species Origin/component 
Positive control Wild type E. coli ECO-SENS 
Negative control Acinetobacter baylyi (Nielsen et al., 1997) 
Water control - ddH2O  
 
 
3.3.3 DNA fingerprinting using Randomly Amplified Polymorphic DNA (RAPD) PCR 
technique 
In this study, RAPD PCR was used to analyze the DNA fingerprinting in the mutated E. coli 
strains. RAPD can be explained by the citation: “RAPD markers can also provide an efficient 
assay for polymorphisms, which should allow rapid identification and isolation of 
chromosome-specific DNA fragments.” (Williams et al., 1990). RAPD PCR was run on all 
strains K56- 22, 41 and 78 mutants for characterization (see Appendix 1: all mutants isolated 
in this study).  
 
3.3.4 DreamTaq master mix 
DreamTaq master mix 2x (Thermo Scientific™, Norway) was used when running the RAPD 
PCR program. According to the manufacturer, the solution contains a total volume of 1,25 ml 
which includes: DreamTaq DNA polymerase, 2x DreamTaq buffer, dNTP’s and 4 mM mgCl2. 
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Each PCR tube (volume 0.2 ml) contained 15 µl Master Mix, 5 µl M13 primer (5 µM), 3 µl 
ddH2O and 2 µl of DNA template. The RAPD-1 thermocycler program was used (see Table 3). 
 
3.4 Gel electrophoresis 
Gel electrophoresis is a lab technique for separation of DNA or proteins based on their size. An 
electrical field passing through the gel will make the DNA move from cathode (negatively 
charged) to anode (positively charged) where the oxidation is taking place. DNA has a 
negatively charged backbone because of all the phosphate groups allowing the DNA to travel 
towards the positively charged end. 1xTAE buffer covering the whole gel was used to conduct 
the electricity. 2% agarose gel was prepared by dissolving 2 g agarose (Seakem® LE agarose) 
in 100 ml 1xTAE buffer and microwaved until the agarose was dissolved. 20 µl ethidium 
bromide (EtBr) (1 mg/ml stock solution, Sigma Aldrich, Germany) was added into the agarose 
after the solution had cooled down to 50-60 °C. The gel was poured directly into the 
electrophoresis chamber (20x15 cm) and allowed it to harden for 20-30 minutes. The EtBr will 
fluorescence when exposed to the Ultra-Violet (UV) light making the bands visible. 10 µl of 
PCR product is mixed with 2µl loading buffer (6x). A molecular marker (SmartLadder) was 
added in the first and the last well as a reference since the sizes of the fragments were known. 
Each well was filled with 10 µl of finished PCR product and the same applied to the ladder. 
The gel was run for one hour at 90 volt. All the gels were visualized in the Gel Doc 2000 Trans 
illuminator (BioRad, Norway) using the software Quantity One (BioRad, Norway).   
 
3.5 Minimal Inhibitory Concentration by E-test 
E-test (epsilometer test) was used to determine the antibiotic susceptibility of the strains, more 
specifically their minimal inhibitory concentration (MIC) (Brown and Brown, 1991). The thin 
plastic strip contained a gradient of antibiotic, in this case, both trimethoprim and ciprofloxacin 
E-tests had a concentration from 0.002 - 32 mg/L (Liofilchem®, Italy). 
One single bacterial colony was suspended in 3 ml of saline (0.9% NaCl) until a McFarland of 
0.5 was achieved. The E-test was performed on a regular LB agar plate by using a sterile cotton 
tip to spread the 0.5 McFarland solution on the plate. The E-test strip was carefully placed in 





value was determined.  The E-test was determined for the wild type strains (shown in Table 7) 
to estimate at which antibiotic concentration LB agar plates should be prepared for generation 
of antibiotic resistant mutants. The mutants generated from each strain were also tested again 
by E-test to see if the MIC value had changed. The strains’ MIC values for ciprofloxacin and 
trimethoprim were determined.  
 
3.5.1 MIC reading using twofold dilutions  
All MIC readings was being determined according to the E-test principle by Citron and his team 
and wrote in their paper saying: “The E-test MICs that were between the standard twofold 
dilution steps were rounded to the next higher step for comparison with agar dilution MICs.” 
(Citron et al., 1991). For instance, a MIC determined to be 0.38 µg/ml on E-test can be rounded 




Figure 6: This figure illustrates the twofold values of 
the E-test used to determine the MIC value of the mutant 
and wild type strains used in this study 
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3.6 Growth curve measurements  
In this experiment, the following strains were used to generate growth curves: 
 
1) TP mutants (K56-22, 41 and 78) vs wild type strains (K56- 22, 41 and 78) 
2) CIP mutants (K56-22, 41 and 78)  vs wild type strains (K56- 22, 41 and 78) 
3) TP + CIP mutants (K56-22, 41 and 78) vs wild type strains (K56- 22, 41 and 78) 
 
Growth curve measurements were used to determine relative fitness for each mutant-versus-
wild type-combination and conducted with 2x4 parallels for each combination resulting from 
two readings (two biological replicates). For the overnight cultures, wild type strains (K56- 22, 
41 and 78) and respective mutant strains (K56- 22, 41 and 78) freeze stock cultures were used 
to inoculate 2 ml of LB. Incubation for 16 hours followed (37 °C, 150 rpm). A dilution of 
1:2000 was prepared for this experiment by mixing 100 µl of the overnight culture with 9.9 ml 
of saline (NaCl 0.9%) resulting in a 1:100 dilution. Further on, 500 µl of the 1:100 dilution was 
diluted with 500 µl of saline (1:2 dilution) into Eppendorf tubes (2 ml) resulting in a 1:200 
dilution. A clear 96-well microtiter plate (volume per well = 0.2 ml, BD Falcon™, USA) was 
filled with 180 µl of liquid LB (8 parallels x 6 rows) and the last 2 rows x 6 parallels with 200 
µl as blank control. The three first rows (from top to bottom) were filled with 20 µl of 1:200 
dilution (resulting in a final dilution of 1:2000) with the respective mutant (per wild type strain) 
that was chosen for measuring the growth, and the same applied to the wild type strains and the 
remaining rows. For the parallels, the four first wells (from left to right) where filled with the 
first replicate and the remaining four wells were filled with the second replicate (see Figure 7 
for setup). The outermost wells remained empty due to expected medium evaporation. All 
microtiter plates were incubated at 37°C for a total of 24 hours. OD (Optical Density) 
measurements were taken every 20 minutes at a wavelength of 650 nm. The plates were shaken 
between readings (constant shaking for 16.65 minutes). This resulted in 73 reads in total. The 
measurements were saved as txt.-documents and used as raw data in Excel for calculation of 
the growth rate. The experiment was performed using the VersaMax® Microplate Reader and 







3.7 Calculation of generation time  
The growth rate was calculated for every readings from each strains (both mutants and wild 
type strains) using the following equations:  
 




(2) Generation time = 
Log2
slope












N1 is the final cell number and N0 is the initial cell number resulting in a linear logarithmic 
plot. N0 represents the lowest point on the linear plot whereas the N1 represents the highest 
Figure 7: Illustrating with colours on how the 96-well was setup in this experiment to measure the 
growth rate between the mutant and the wild type strains.  
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point. T is time (hours or minutes) of exponential growth and t1 and t0 is expressed the same 
way as N(1,0).  
 
3.8 Calculation of relative generation time as a fitness measurement 
In this study, the fitness are determined using the generation time due to individually growth 
curve measurement and not direct competition assays. The generation time was calculated for 
each mutant and wild type strains that were selected to measure the growth curve (see 3.7). 
Generation time is the time it takes for the bacteria to double using the exponential phase of 
growth.  
 
Relative generation time: Average for each mutant strain was being calculated before 
determining the relative generation time using the following equation:  
 





Relative generation time > 1 means that the wild type strain has a shorter generation time 
compared to the mutant strain. When relative generation time < 1 it means the mutant strain has 
a shorter generation time. A relative generation time = 1 means there is no difference in the 
generation time. The shorter the generation time the higher the fitness, it takes less time to get 
out of the lag phase and reach the exponential phase of the growth curve. The relative fitness 
was calculated in minutes as the concept of time.  
 
3.9 Statistical analysis  
The growth curve experiment was carried out with at least four biological replicates. The 
calculation of averages, standard deviations, standard errors and 95% confidence intervals for 
each replicate was performed in Microsoft Excel 2013. A two-tailed student test (t-test) was 





4 RESULTS  
To test the main hypothesis this study, the generation, confirmation and characterization of 
spontaneous mutants, with reduced susceptibility to selected antimicrobial agents, was 
essential. In the following section, results from MIC and -fitness measurements of wild type 
and mutant strains using growth curves to calculate generation times can be found in this part 
of the thesis.  
 
4.1 Generation of single and double mutants  
According to the MICs of the E. coli wild type strains (see section 2.2.4). Trimethoprim plates 
in a concentration of 4, 8, 16 and 32 µg/ml and ciprofloxacin plates in concentration of 0.1 and 
0.25 µg/ml, were prepared for the generation of spontaneous mutants. Table 5 shows an 
overview of all mutants isolated in this study. Mutants were selected for based on the physical 
characteristics of E. coli growth such as the colony color, size, and smell. The colony size 
differed depending on length of incubation. The longer the incubation time, the larger the 
colonies grew. Most colonies were preferably selected from the highest antibiotic concentration 
possible as long as there was a visible growth. 
Trimethoprim resistant mutants: most colonies were selected from plates amended with 
trimethoprim in a concentration of 4, 8 and 16 µg/ml. Using the concentration of 32 µg/ml 
yielded very little or no growth. Since the concentration of 32 µg/ml trimethoprim in agar 
medium clearly exceeded the MIC for this antibiotic in the respective E. coli wild type strains 
and no spontaneous mutants were yielded at this concentration. The aim was to isolate mutant 
colonies from the highest antibiotic concentration possible. Here, at concentration of 16 µg/ml 
trimethoprim showed to be ideal to generate spontaneous resistant mutants. Most colonies could 
already be detected after one day of incubation at 37°C and after two days, most of the colonies 
were large enough to be isolated for further characterization.  
Ciprofloxacin resistant mutants: despite several attempts to generate mutants on 
ciprofloxacin containing plates with 2 and 4 µg/ml were unsuccessful, the antibiotic 
concentration was reduced down to 0.1 and 0.25 µg/ml. Most colonies were detected at a 
ciprofloxacin concentration of 0.1 µg/ml, and very few colonies (4-5 colonies per 10 plates) 
were detected on plates containing 0.25 µg/ml of this antibiotic. On plates supplemented with 
0.1 µg/ml ciprofloxacin plates, as much as 10-20 colonies could be detected per plate.  
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Trimethoprim and ciprofloxacin resistant double mutants: The generation of double 
mutants was carried out by plating same trimethoprim resistant mutants on ciprofloxacin 
containing (0.1 and 0.25 µg/ml ciprofloxacin), see method section 3.1.2 for generation of 
double mutants. Most mutants were detected on plates amended with 0.1 µg/ml of ciprofloxacin 
(approximately 10-20 colonies per plate), however, approximately 4-5 colonies per 10  agar 
plates  were detected  in 0.25 µg/ml ciprofloxacin.   
The process of colony isolation: approximately ten mutants from each strain were isolated 
after single colony streaks on antibiotic containing plates. The resistant isolates were frozen 
down as a LB-glycerol freeze stock (for more details: see section 2.3.2).  
 
Table 5: Numbers of spontaneous single and double mutants isolated for each E. coli wild type 
strain.  
Strain Number of TP mutants Number of CIP mutants Number of TP+CIP mutants 
K56-22 11 10 6 
K56-41 10 10 7 
K56-78 10 14 4 
Sum 31 34 17 
TP – trimethoprim resistant; CIP – ciprofloxacin resistant 
 
In total, 82 mutant isolates were frozen down (Table 5). Every now and then, bright, yellow 
colonies could be observed among mutant colonies that were streaked on antibiotic containing 
agar plates after an incubation of 24-36 hours from the initial plates. Although possible sources 
for contaminations eliminated as good as possible (sterilization of LB agar, horizontal air flow 
under pouring process (LB agar plates)), the yellow colonies were detected to be contaminations 
and not E. coli mutants according to a PCR analysis (see Figure 10). The yellow colonies were 
mostly observed when generating mutants on ciprofloxacin containing plates, but no when 
generating mutants on trimethoprim containing plates. They were only detected on the initial 
plating of the overnight culture (ONC) on ciprofloxacin containing plates. Some yellow 
colonies could also be detected when generating double mutants, yet again, the double mutants 
were generated on ciprofloxacin plates. The exact source of contaminations is unknown. To 
that end, one possibility could be the large area of agar plates exposed to air when streaking and 





in filter sterilization during the making of antibiotic stock solution of ciprofloxacin. Due to 
growth of yellow colonies on ciprofloxacin containing plates may most likely mean that the 
yellow colonies are resistant too.  
 
4.1.1 Confirmation of single and double mutants using paper strip method 
Mutant isolates selected for further confirmation were picked using a sterile paper strip and 
streaked fresh antibiotic containing plates as described earlier in section 3.2.1. Figure 8 shows 
an example of several mutant isolates in one plate (divided into sections), including one section 
of no growth (negative control strain: ciprofloxacin susceptible ancestor). This proofed, that the 
colonies that were picked for further streaking were resistant against the concentration of 
antibiotic that was present in the plate, which was 0.1 µg/ml of ciprofloxacin in this case. 
Mutants that were selected for further characterization were either streaked on the same 
antibiotic concentration that they were originally obtained from or on an antibiotic 
concentration that was approximately two-fold lower in concentration. This reduced the chance 
to inhibit growth of the mutant cells. All mutant isolates (82 in total) that were chosen for further 
characterizations were treated like this.  
  
Figure 8: Figure showing an example of five CIP mutant colonies (generated from 
K56-22) that were streaked in sections on a LB agar plate containing 0.1 µg/ml 




4.2 Characterization and confirmation of E. coli mutants using RAPD1-PCR  
RAPD1-PCR  was the chosen method to confirm if the mutants belonged to E. coli species. 
Some of the mutants did not show any fingerprints on the gel image, possibly due to a faulty 
preparations of PCR reactions. However, a total of nine mutants (three isolates from each 
mutational background (TP, CIP and TP+CIP) were selected to measure the growth rate (See 
Appendix 1: mutant marked with colours).  
Isolated mutants were characterized using the RAPD1 thermocycling program. Figure 9 shows 
an example of gel images of PCR products using RAPD1-PCR to screen all eighty-two mutants 
collected individually from each strain resistant to either TP or CIP and TP+CIP. Most RAPD 
fingerprinting analysis contained 10 PCR samples in one gel electrophoresis experiment. The 
PCR samples of E. coli mutants were compared to the respective ancestor E. coli strain (positive 
control) (See section 3.3.2 for PCR controls). The typical band pattern obtained through gel 
electrophoresis differed between 2 and 4 bands. Bands observed at 600 and 800 base pair (bp) 
were characteristic for E. coli, also according to the positive control.  
 
 
Figure 9: Gel picture of RAPD1-PCR products observed on a 2% agarose gel showing four 
CIP mutants from strain K56-78. L: molecular marker (SmartLadder) (See Appendix 5: 
molecular marker). 1-4: E. coli mutants (strain K56-78). P: ancestral control, E. coli strain. N: 






As mentioned in section 4.1, contaminations could as well be detected when using the RAPD1-
PCR analysis. The band pattern of a contamination could obviously not be comparable to the 
positive control (see Figure 10). A. baylyi was used was used as a negative control, resulting in 
a visible difference in bands distribution after RAPD1-PCR analysis.  
 
Figure 10: Image of ten PCR samples (CIP mutants of E. coli K56-22). L: SmartLadder, Lanes 
1-10: E. coli mutants, P: ancestral control, E. coli strain N: Negative control A. baylyi. W: 
ddH2O control. Lane 2 and 3 could be contaminations due to differences in band pattern. 
 
Bands showing in water controls: it was not supposed to have any bands showing in the water 
control, however, the bands that occured in the water control (at 1 kb, see W – water control 
see Figure 8) was due to the non-amplified DNA products from the M13 primer added in the 
PCR reaction without the DNA template. Grisham and his team can explain the bands that were 
showing in the water control where they wrote in their article saying: “…in RAPD-PCR 
literature is the existence of primer-derived, nonspecific amplification products in negative 
control reactions containing all the reaction components except for a DNA template.” And 
further they said: “These artifacts presumably are absent if a genomic DNA template is included 




4.3 Determination of Minimal Inhibitory Concentration using E-test 
The minimal inhibitory concentration (MIC) of TP, CIP and TP+CIP mutants was determined 
using E-test as described in section 3.5. All MICs presented in the tables below were rounded 
up according to the twofold dilution using the E-test principle as described in the method section 
(see Figure 6 in section 3.5.1) and this is also described in the European Committee on 
Antimicrobial Susceptibility Testing (EUCAST). Raw data of the mutants’ MICs (not rounded) 
(Appendix 1: all mutants collected in this study). According to MIC and EUCAST (clinical 
breakpoints), it is possible to group the isolates into susceptible/intermediate or resistant 
mutants of E. coli. Initially, the wild type strains were all susceptible. Exposure to antibiotic 
concentrations around MIC or higher eventually led to reduced susceptibility due to 
spontaneous mutations. All mutants that are presented in this thesis are most likely single step 
mutants with reduced susceptibility to trimethoprim and ciprofloxacin. 
 
4.3.1 Classification of resistance levels in bacteria  
To be able to compare how susceptibility of wild type E. coli strains would change after 
exposure to antibiotics, E-test was used as a method to determine MIC values of wild type and 
mutant strains, respectively. The clinical breakpoints of trimethoprim and ciprofloxacin 
presented in Table 6 indicate at which MIC of the chosen antibiotic the resistance occurred.  
 
Table 6: Clinical breakpoints adopted from EUCAST (V. 5.0, valid from 2015-01-01) 
Antimicrobial agent Susceptible ≤ µg/ml Intermediate µg/ml Resistant ≥ µg/ml 
Trimethoprim 2 2 - 4 4 








4.3.2 MICs determined for wild type strains 
Table 7 show an overview of all three E. coli wild type strains and their determined MICs for 
trimethoprim and ciprofloxacin. For trimethoprim, a clear variation in the wild type MICs could 
be observed, with concentration ranging from 0.25 to 1 µg/ml, while the MICs from 
ciprofloxacin E-tests were quite consistent at a concentration of 0.016 µg/ml for all wild type 
strains. When comparing the E. coli wild type MICs to the EUCAST clinical breakpoints, all 
our strains were characterized as susceptible, as originally reported (Kahlmeter, 2000)  
 
Table 7: Minimal inhibitory concentrations of E. coli wild type strains 
WT Strains Trimethoprim (µg/ml) Ciprofloxacin (µg/ml) R/IM/S 
K56-22 0.25 0.016 S 
K56-41 0.5 0.016 S 
K56-78 1 0.016 S 
WT – wild type; R - resistant; IM – intermediate; S – susceptible 
 
 
4.3.3 MICs determined for single and double mutants  
Single mutants: 
MICs were determined for mutant strains as mentioned above. TP22 and TP78 mutants had 
MICs beyond a concentration of 32 µg/ml, which displayed increased in MICs by 128 (for 
TP22) and 32 (TP78) folds compared to the MICs of the wild type strains. TP41 had a MIC of 
6 µg/ml, which results in a 12 times increased concentration (see Table 8) compared to its wild 
type strain. When determining MICs for TP22 and TP78, the plate (with a MIC above 32 µg/ml) 
was covered with bacterial growth on the plate and no inhibition zone could be detected, as for 
TP41 a bigger inhibition zone was observed. The TP mutants are classified as resistant because 
of a MIC value above 4 µg/ml (see Table 6).  
For the CIP mutants, MICs of 0.5 µg/ml were determined for ciprofloxacin (see Table 9). When 
comparing with the wild type MICs for ciprofloxacin (0.016 µg/ml), clear increase in the MICs 
by over 30 times can be observed. According to EUCAST clinical breakpoints, all CIP mutants 




Table 8: trimethoprim mutants and their MIC for trimethoprim 
Strain Trimethoprim (µg/ml) R/IM/S 
TP22 > 32 R 
TP41 6 R 
TP78 >32 R 
TP – trimethoprim resistant; R - resistant; IM – intermediate; S – susceptible 
 
 
Table 9: CIP mutants and their MIC for ciprofloxacin 
Strain Ciprofloxacin (µg/ml) R/IM/S 
CIP22 0.5 IM 
CIP41 0.5 IM 
CIP78 0.5 IM 
CIP – ciprofloxacin resistant; R - resistant; IM – intermediate; S – susceptible 
 
 
Double mutants:  
MICs for the double mutants were determined by co-workers involved in a collaborating 
project: MIC were determined based on E-test carried out on Muller Hinton agar II-plates with 
a 0.5 McFarland bacterial suspension and an incubation time of approximately 16 hours at         
37 °C. The MICs for trimethoprim were determined to be 0.5, 1 and 8 µg/ml in the double 
mutants, resulting in a variation in the MICs. Only TP+CIP78 can be classified as resistant with 
a trimethoprim concentration at 8 µg/ml, while the other TP+CIP (22 and 41) can be classified 
as ‘suscpetible’ due to concentrations of 0.5 and 1 µg/ml in trimethoprim, resulting in TP+CIP 
being the most susceptible ones to trimethoprim.  While the MICs for ciprofloxacin were more 
consistent, resulting in a concentration of 0.5 µg/ml for all three double mutants. As for the 
ciprofloxacin, all TP+CIP mutants were classified as ‘intermediate’ to ciprofloxacin (MIC 






Table 10: Table of TP+CIP double mutants and their MICs for each antibiotic.  
Strain Trimethoprim (µg/ml) R/IM/S Ciprofloxacin (µg/ml) R/IM/S 
TP+CIP 22 0.5 S 0.5 IM 
TP+CIP 41 1 S 0.5 IM 
TP+CIP 78 8 R 0.5 IM 
TP – trimethoprim resistant; CIP – ciprofloxacin resistant; R - resistant; IM – intermediate; S – susceptible 
 
 
4.3.4 MICs determined for TP mutants using Ciprofloxacin E-tests 
Before generating double mutants, MICs of the TP mutants for ciprofloxacin were determined 
using E-test strips (see Table 11 for MICs). The MIC of ciprofloxacin in TP mutants was 
expected to be the same as for the MIC determined in wild type strains. However, the MICs of 
TP22 and 78 being 0.125 and 0.031 µg/ml for ciprofloxacin had increased compared to wild 
type strains (22 and 78) with their MICs being 0.016 µg/ml (see Table 7 for MIC of E. coli wild 
type strains). TP41 showed the same MIC as WT41. All TP mutants can be classified as 
‘susceptible’ to ciprofloxacin according to EUCAST clinical breakpoints. A possible “cross-
resistant” seem to had occurred in two of the TP mutants towards ciprofloxacin.  
 
Table 11: MIC value for ciprofloxacin determined in TP mutants that were chosen for 
generating double resistant mutants.  
Strain Ciprofloxacin (µg/ml) R/IM/S 
TP22 0.125 S 
TP41 0.016 S 
TP78 0.031 S 






4.4 Growth curve and generation time 
Nine mutant isolates, one from each strain for every resistant combination (TP, CIP and 
TP+CIP) were chosen based on the MICs and RAPD1-PCR confirmations. Growth curve 
measurements were conducted using the VersaMax™ Microtiter plate reader and the software 
SoftMax Pro. The growth started approximately after 1 hour and 20 minutes, according to the 
raw data sheet for all plate readings in this study. The lag phase, which occured before 1 hour 
and 20 minutes is not displayed in any of the growth curve graph due to negative values 
(negative measurements for Optical Density (OD) were not detected). In this study, six plate 
readings were conducted, but only two of them are displayed in this section as examples. Figure 
11 for example shows that trimethoprim mutant, TP22, was the only strain in this study that had 
much slower growth compared to the other E. coli wild type or mutant strains. The other growth 
curves of CIP and TP+CIP showed that the growth of the mutant and wild type strain was 
similar to each other, as shown in Figure 12. 
 
Figure 11: Graph illustrating the growth curve of TP mutants and  respective WT strains. There 
























Figure 12: Growth curve of CIP mutants and respective WT strains. It seems that mutant CIP41 
and its respective WT41 strain are similar in growth rates with a slightly longer generation time 
compared to the other strains displayed here.   
 
 
4.4.1 Calculation of generation time using growth curve measurements 
The generation time of the mutant and wild type strains was calculated from growth curve 
measurements using a semi logarithmic plot to determine the endpoint-value of the slope. 
However, no semi logarithmic plot was used to determine the starting point of the slope. This 
is because the lag phase of the growth curve was being concealed during the logarithmic scaling. 
At least three values were manually chosen to determine the slope for each mutant and wild 
type strain. The generation time was calculated using Microsoft Excel 2013. The generation 
time is calculated for all biological replicates for each mutant and wild type strain (N=4) and 
each biological replicate is an average of 4 parallel readings for each mutant and wild type 
















CIP 22 CIP 41 CIP 78 WT 22 WT 41 WT 78
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Table 12: Generation time (in minutes) for TP mutants and WT strains, respectively.  
N TP22 TP41 TP78 WT22 WT41 WT78 
1 40 29 28 29 24 27 
2 38 28 28 29 30 27 
3 38 29 31 29 28 31 
4 37 31 30 29 31 29 
Mean 38 29 29 29 28 29 
TP – trimethoprim resistant; WT – wild type 
 
Table 13: Generation time (in minutes) for CIP mutants and WT mutants, respectively. 
N CIP22 CIP41 CIP78 WT22 WT41 WT78 
1 28 27 27 27 29 30 
2 27 27 27 28 32 29 
3 32 28 31 29 33 28 
4 32 33 31 30 30 30 
Mean 30 29 29 29 31 29 
CIP – ciprofloxacin resistant; WT – wild type 
 
Table 14: Generation time (in minutes) for TP+CIP mutants and WT mutants, respectively. 
N TP+CIP22 TP+CIP41 TP+CIP78 WT22 WT41 WT78 
1 33 28 31 30 30 28 
2 30 30 31 30 31 28 
3 30 27 29 27 23 28 
4 29 29 30 28 28 28 
Mean 31 29 30 29 28 28 








4.5 Relative generation time as a measure of fitness 
The fitness cost of carrying a resistant mutation was investigated by comparing the growth rates 
of the spontaneous antibiotic mutant isolates and the respective wild type strains. Relative 
generation times were calculated and are considered a measurement for fitness in this study. 
The relative generation time is calculated using equation (4) referred in section 3.8. Figure 13 
is a graphical representation of the relative generation time of the three combinations of TP, 
CIP and TP+CIP mutants with their respective wild type strain. 
The relative generation time for WT22/TP22 was found to be 0.76 (± 0.028 confidence interval, 
n=4), which can be translated into an average of 24% more rapid growth of WT22 compared to 
TP22, meaning that there is a significant difference in the generation time between these two 
(p-value = 6.33*10-06 (0.00000633),  p ≤ 0.05). As for the other TP mutant strains (41 and 78), 
the relative generation times resulted in a difference of 3%, (0.966 and 0.974 respectively) faster 
growth in the WT strains (41 and 78) as compared to the mutant strains only, and no significant 
differences were detected (p-value = 0.57 and 0.56). This could also be observed by in the 
average generation time for TP78 and WT78, where both strains had an average generation 
time of 29 minutes (see Table 12).  
The relative generation times determined for CIP mutants showed almost no difference when 
compared to the generation times of the respective WT strains. CIP22 was the only strain that 
had a slower growth compared to its WT22 strain. On average, WT22 and CIP22 has a 4% 
difference in generation time (0.958 ± 0.055 confidence interval), resulting in faster growth for 
the wild type strain. For mutants CIP41 and CIP78, a relative generation time above one was 
calculated (1.078 and 1.009 respectively) meaning that the CIP41 and 78 had 7.8% and 0.9% 
longer generation time compared to the respective WT strains. However, no significant 
differences were detected (p-value ≥ 0.05) and all relative values could be defined as equal to 
one (relative values = 1 meaning no difference in the generation time).  
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Calculation of relative generation times for the double mutants (TP+CIP) resulted in values of 
0.94 and 0.98 (relative value = 1) for TP+CIP22 and 41 meaning there is an average of 6% and 
2% of faster growth in the respective WT strains (22 and 41). No significant differences were 
detected with a p-value of 0.18 for TP+CIP22 and a p-value of 0.80 for TP+CIP41. As for the 
TP+CIP78 in contrast, there was a significant difference detected with a p-value of 0.0033 (p-
value ≤0.05) and a relative generation time of 0.93, translated into an average difference in 
generation time of 7% (± 0.03 confidence interval) and faster growth in the WT78 strain 















































































Figure 13: Fitness measurements using relative generation time values for the three 
mutant/WT combinations; TP mutants/WT (A), CIP mutants/WT (B) and the double mutants 
TP+CIP/WT (C); relative generation time is represented in bars with colors representing each 







Trindade et al. showed in 2009, that different types of epistasis exist (both, positive and 
negative) in E. coli mutants containing antibiotic resistance mutations (Trindade et al., 2009). 
The key findings in this thesis are that potential positive epistatic interactions seem to occur by 
chance in the double mutant TP+CIP22 using relative generation time as a measure of fitness. 
The TP+CIP22 double mutant (average generation time of 31 minutes) showed a reduced 
generation time compared to the single mutant TP22 (average generation time of 38 minutes), 
which results in an average difference in generation times of 7 minutes.  Interestingly, negative 
epistasis was also observed in all double mutants (TP+CIP) in which the MIC towards 
trimethoprim had decreased compared to the respective single TP mutants. This change in MIC 
occurred without changes in growth rates.   
One trimethoprim resistant mutant (TP22) displayed a severely increased generation time when 
compared to WT strains, consistent with multiple reports on initial fitness costs of resistance 
towards other antimicrobial agents (Nilsson et al., 2003, zur Wiesch et al., 2011, Björkholm et 
al., 2001). However, acquisition of reduced ciprofloxacin susceptibility together with reduced 
trimethoprim susceptibility in the double mutant restored the generation time to WT levels. 
These data strongly suggest a positive epistatic interaction between the mutations on the 
generation time as a measurement of fitness.  
Other TP mutants (TP41 and TP78) showed no significant difference in generation time 
compared to their respective susceptible wild type strains. Mutations conferring reduced 
susceptibility to antimicrobials that does not reduce fitness are also reported in the literature 
(Andersson and Hughes, 2010). One study reported the biological cost of resistance in a 
fosfomycin resistant E. coli using growth rates as proxy for relative fitness and showed no 
significant difference in growth rates between the resistant strain and the susceptible strain in a 
fosfomycin free environment (Nilsson et al., 2003). In addition, no significant differences in 
average generation time were detected between the double mutant TP+CIP (K56-22, 41 and 
78) strains and their respective WT strains. All single and double mutants and their respective 
WT strains, except from single mutant TP22, had similar average generation times of 
approximately 30 minutes. However, no statistical analysis was performed between the 
combinations. We also found that there were no significant differences in fitness cost between 
the acquisition of one (single resistant mutants)-, or two (double resistant mutants) mutations 
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leading to a trimethoprim and/or ciprofloxacin phenotype. These findings suggest that the 
presence of different mutations resulting in reduced susceptibility to trimethoprim and/or 
ciprofloxacin in this study, and that these mutations come with different, but not statistically 
significant fitness costs. 
Fitness cost in CIP mutants showed no significant difference in generation time compared with 
the respective WT strains. One study reported that single mutants (par and gyr) of S. pneumonia 
(strain R6) had a reduced fitness cost due to acquisition of first-step (low level) quinolone 
resistance, while the addition of a second resistance gene mutation (par and gyr) did not affect 
the fitness cost and other had no measurable fitness cost (Rozen et al., 2007).  
The prolonged generation time of TP22 might be influenced by the genetic background of the 
E. coli strains we used and maybe by the fact that the trimethoprim resistance is costly for that 
particular E. coli strain, even though it did not apply to the other TP mutant strains. Trindade 
and her team also showed that positive epistatic interaction that had occurred in alleles and led 
to antibiotic resistance, was dependent on a certain genetic background (Trindade et al., 2009). 
They also meant that the bacterial evolution would favour the positive epistatic interations if it 
occurred, making the bacteria more fit and be able to survive and outcompete other susceptible 
bacteria.  
In a clinical and public health point of view, an antimicrobial treatment using ciprofloxacin 
against E. coli resistant to trimethoprim only, can possibly lead to a positive epistatic interaction 
rendering the trimethoprim resistant strain more fit, depending on the diverse genetic 
background in bacteria. Studying epistasis is important for us in order to understand the 
generation of diversity among bacteria through random gene-gene or mutational interactions 
leading to a specific phenotype (Mani et al., 2008).  
Negative epistasis was also observed in this study. A decrease in MIC was determined for 
trimethoprim in all TP+CIP double mutant strains (K56-22, 41 and 78) compared to the 
respective TP single mutants (K56-22, 41 and 78). The MIC value for TP were determined to 
be 12 to 64 times decreased in the double mutants TP+CIP (MIC value presented in Table 8 
and Table 10). These data suggest an epistatic interaction of unknown mechanism where 
acquisition of a mutation that reduce susceptibility to ciprofloxacin re-sensitizes the bacterium 
to trimethoprim. This is interesting from a treatment perspective. The result demonstrates 





rates. These preliminary data are very interesting, but need further characterization and 
verification.    
Epistatic interactions between two acquired resistance mutations, TP and CIP, were identified 
by calculation of generation time and determination of MIC values for mutant and WT strains. 
Analysis and comparison of epistatic patterns by quantifying epistasis could be determined 
using mathematical models or/and describing fitness landscapes (Schenk et al., 2013), or like 
we did, by detection of qualitative changes of bacterial phenotypes in bacteria, reviewed in 
(Phillips, 2008).  
Two of three trimethoprim resistant mutants displayed elevated ciprofloxacin MIC’s compared 
to WT strains. Such “cross-resistance” has caught revived attention recently and was termed 
“collateral resistance” by (Imamovic and Sommer, 2013) (see Table 7 and Table 11). From a 
clinical perspective, these data suggest that the temporal order of drug consumption is not 
random. This means if treated with trimethoprim first, the reduced susceptibility towards 
ciprofloxacin requires perhaps higher doses of ciprofloxacin. This would initially need 
evaluation by performing time-kill experimented as seen in ((Imamovic and Sommer, 2013)). 
This was not part of the hypothesis being test here, but a result worth to be mentioned.  
Susceptibility-testing by E-tests was a quick way to determine a strains’ susceptibility to either 
trimethoprim or ciprofloxacin. MICs were read manually by the naked eye making the MIC 
value differ from time to time. Reading the E-test strips, especially the trimethoprim strips, was 
challenging due a bacteriostatic effect of this antibiotic. To minimize variations in E-test 
readings in this study, the procedure was standardized regarding incubation time, culture 





5.1 Determination of fitness cost using growth rate measurements 
In this study, we measured growth rates of mutant and wild type strains to be able to determine 
the fitness effect of a mutation. This method resulted in very consistent data for generation 
times. The generation times of the chosen E. coli wild type strains differed only in a couple of 
minutes, which was very good. However, the method cannot be considered ‘optimal’ for my 
study. For an optimal fitness reading, the methodological gold standard would be a direct head-
to-head competition between a wild type and a mutant strain. In this scenario, the growth rates 
of two or more strains (1:1) directly competing with each other in the same vessel and media 
are measured (Trindade et al., 2009). When performing direct competition assays, relative 
fitness can be calculated between the two strains. Growth curve measurements make it harder 
to see the real fitness cost considering that the less fit bacteria has its own space to grow (spatial 
factor) and its own medium (nutritional factor). Nilsson and his team had measured the fitness 
cost in E. coli by only using the relative growth rates both in rich LB medium and human urine 
in the presence and absence of fosfomycin, resulting in different results depending on which 
media was used (Nilsson et al., 2003). The introduction of different variables like choosing 
different media (such as LB, urine, saline, blood etc), temperature, and pH-adjustments and so 
on can be considered in a continuation of this project.   
 
5.2 Possible limitations of using growth rates as fitness measurements 
For the calculation of generation times of E. coli mutant and wild type strains, the start- and 
endpoint-measurements of the linear slope in the exponential phase of the growth were chosen 
manually. This was a time-consuming process and a possible source for bias leading to a fault 
in the calculation of generation times. This would be easier if readings were taken for example 
every 10 minutes: that could help us determine the linear slope in the exponential phase much 
easier since there were more values to choose from. Since E. coli had a doubling time of 30 
minutes, it was also hard to determine the exact doubling time as readings were set to every 20 






5.3 The possible reversal of antimicrobial resistance 
From a clinical point of view, it is interesting to know whether the resistance towards 
trimethoprim and ciprofloxacin would decrease or perhaps reverse in the absence of 
antimicrobial drugs. However, the reversal of antibiotic resistance is not as easy as it may seem. 
The chances to reverse antibiotic resistance in bacteria may actually be impossible and the time 
frame for this event depends on time without antibiotic exposure, bacterial species and 
antimicrobial agent to which resistance exists (Johnsen et al., 2009). An intervention study 
showed that a reduction in the consumption of trimethoprim did not result in reduced 
frequencies of trimethoprim resistance, suggesting a low if any cost of resistance (Sundqvist et 
al., 2010). Even though the data presented here should be interpreted with caution, our data also 
points out that trimethoprim resistance can be “cost free” making reversal of resistance difficult. 
This is consistent with previous reports that suggest that it may take many years to observe a 
visible change in the frequency of resistance, even if resistance is costly (Levin, 2001, Schrag 
et al., 1997, Johnsen et al., 2011).   
 
5.4 Characterization of trimethoprim and ciprofloxacin resistance in clinical E. 
coli strains 
In this study, we only used RAPD1-PCR to characterize the mutant and wild type strains, which 
was a simple method. An other possible method for species identification would be to apply 
16S rRNA sequencing to the isolated E. coli mutants (Kawai et al., 2002).  It would be also 
interesting to see where in the genome the mutations had occurred. Characterization of mutants 
using PCR to first amplify genes that are responsible for fluoroquinolone resistance traits and 
further use these PCR products for DNA sequencing, was done in the paper of (Strahilevitz and 





5.5 Concluding remarks 
Overall, this study showed that being resistant towards trimethoprim or/and ciprofloxacin 
(mutant strain) did not result in a significant reduction of fitness compared to a respective wild 
type strain. A positive epistatic interaction was observed in the TP+CIP22 double mutant 
manifested as reduced generation times compared to the single mutant, TP22. This positive 
epistatic interaction probably resulted from influences the CIP-resistant phenotype had on TP-
resistant phenotype. Interestingly, negative epistasis was also observed at the MIC level where 
a large reduction in TP-MIC was seen following acquisition of ciprofloxacin resistance in the 
double mutants (TP-CP). The incidence of epistatic interactions seems to happen randomly and 
can thus occur unexpectedly considering the genetic diversity in E. coli.  
If the findings here were directly included in the treatment of uncomplicated UTI caused by E. 
coli the positive and negative epistatic effect could influence the treatment with trimethoprim 
and ciprofloxacin. The chance for E. coli of being severely susceptible to trimethoprim is higher 
if it was resistant to both trimethoprim and ciprofloxacin instead of resistant to only 
trimethoprim, if there was a presence of a negative epistatic interaction. Although, this is an in 
vitro study and the conclusions made here cannot be transferred directly to a clinical setting, 
further characterizations of mutants needs to be made. An in vivo study could be considered in 
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Appendix 1: Total of nine tables of mutants collected in this study with the raw MIC value, 
PCR confirmations, steps of growth cycle and at which concentration the mutant was 
isolated from. Mutants that are marked with colors (blue, red and yellow) are the 
mutants that were selected for the growth curve measurements.    
 













 Table B: TP41 mutants isolated in this study 
Trimethoprim, Strain K56-22 
Wild Type MIC: 0,125 µg/ml 
No. Mutants 
(AB concentration) 
PCR E-test (MIC µg/ml) Growth cycle 
(Steps) 
1 1 (16 µg/ml) ✓ >32 4 
2 2 (16 µg/ml) ✓ >32 4 
3 3 (16 µg/ml) ✓ >32 4 
4 4 (16 µg/ml) X >32 4 
5 5 (16 µg/ml) ✓ >32 4 
6 6 (16 µg/ml) ✓ >32 4 
7 7 (16 µg/ml) ✓ >32 4 
8 8 (16 µg/ml) ✓ >32 4 
9 9 (8 µg/ml) ✓ >32 4 
10 A (LB) ✓ >32 4 
11 1 (LB) ✓ >32 4 
Trimethoprim, Strain K56-41 
Wild type MIC: 0,38 µg/ml 
No. Mutants 
(AB concentration) 
PCR E-test (MIC µg/ml) Growth cycle 
(Steps) 
1 1A (16 µg/ml) X 80% from 4 4 
2 2A (16 µg/ml) X 80% from 1,5 4 
3 3A (16 µg/ml) ✓ 80% from 2 4 
4 4A (16 µg/ml) ✓ 80% from 2 4 
5 5A (16 µg/ml) ✓ 80% from 3 4 
6 1B (16 µg/ml) ✓ 80% from 2 4 
7 2B (16 µg/ml) ✓ 80% from 3 4 
8 3B (16 µg/ml) ✓ 80% from 4  4 
9 4B (16 µg/ml) ✓ 80% from 6 4 

























Table D: CIP22 mutants isolated in this study 
  
Ciprofloxacin, Strain K56-22 
Wild type MIC: 0,012 µg/ml 
No. Mutants 
(AB concentration) 
PCR E-test (MIC µg/ml) Growth cycle 
(Steps) 
1 1 (0,1 µg/ml) - 0,38 4 
2 2 (0,1 µg/ml) ✓ 0,25 – 0,38 4 
3 3 (0,1 µg/ml) ✓ 0,25 4 
4 4 (0,1 µg/ml) ✓ 0,38 4 
5 5 (0,1 µg/ml) ✓ 0,38 4 
6 6 (0,1 µg/ml) ✓ 0,38 4 
7 7 (0,1 µg/ml) ✓ 0,5 4 
8 8 (0,1 µg/ml) ✓ 0,38 4 
9 9 (0,1 µg/ml) ✓ 0,38 4 
10 10 (0,1 µg/ml) ✓ 0,38 4 
Trimethoprim, Strain K56-78 
Wild type MIC: 0,75 µg/ml 
No. Mutants 
(AB concentration) 
PCR E-test (MIC µg/ml) Growth cycle 
(Steps) 
1 1 (4 µg/ml) X >32 4 
2 2 (4 µg/ml) ✓ >32 4 
3 3 (4 µg/ml) ✓ >32 4 
4 4 (4 µg/ml) ✓ >32 4 
5 5 (4 µg/ml) ✓ >32 4 
6 6 (4 µg/ml) ✓ >32 4 
7 7 (4 µg/ml) ✓ >32 4 
8 8 (4 µg/ml) ✓ >32 4 
9 9 (4 µg/ml) X >32 4 





















Ciprofloxacin, Strain K56-41 
Wild type MIC: 0,016 µg/ml 
No. Mutants 
(AB concentration) 
PCR E-test (MIC µg/ml) Growth cycle 
(Steps) 
1 1 (0,1 µg/ml) ✓ 0,38 4 
2 2 (0,1 µg/ml) ✓ 0,38 4 
3 3 (0,1 µg/ml) ✓ 0,5 4 
4 4 (0,1 µg/ml) ✓ 0,38 4 
5 5 (0,1 µg/ml) ✓ 0,5 – 0,75 4 
6 6 (0,1 µg/ml) ✓ 0,5 – 0,75 4 
7 7 (0,1 µg/ml) ✓ 0,5 4 
8 8 (0,1 µg/ml) ✓ 0,38 – 0,5 4 
9 9 (0,1 µg/ml) ✓ 0,38 – 0,5 4 
10 10 (0,1 µg/ml) ✓ 0,38 – 0,5 4 
Ciprofloxacin, K56-78 
Wild type MIC: 0,016 µg/ml 
No. Mutants 
(AB concentration) 
PCR E-test (MIC µg/ml) Growth cycle 
(Steps) 
1 1 (0,1 µg/ml) ✓ 0,38 4 
2 2 (0,1 µg/ml) ✓ 0,38 4 
3 3 (0,1 µg/ml) ✓ 0,25 – 0,38 4 
4 4 (0,1 µg/ml) ✓ - 4 
5 5 (0,1 µg/ml) ✓ - 4 
6 6 (0,1 µg/ml) ✓ - 4 
7 7 (0,1 µg/ml) ✓ - 4 
8 8 (0,1 µg/ml) ✓ - 4 
9 9 (0,1 µg/ml) ✓ - 4 
10 10 (0,1 µg/ml) ✓ - 4 
11 1 (0,25 µg/ml) ✓ 0,38 4 
12 2 (0,25 µg/ml) ✓ 0,38 – 0,5 4 
13 3 (0,25 µg/ml) ✓ 0,38 4 






Table G: TP+CIP22 mutants isolated in this study 
 
 


















Double mutants: Trimethoprim + Ciprofloxacin, K56-22 
TP K56-22 MIC: 0,008 µg/ml ciprofloxacin 
No. Mutants 
(AB concentration) 
PCR E-test (MIC µg/ml) Growth cycle 
(Steps) 
1 1 (0,25 µg/ml cip) ✓ - 8 
2 2 (0,25 µg/ml cip) ✓ TP: 0,5 
CIP: 0,5 
8 
3 3 (0,25 µg/ml cip) ✓ - 8 
4 4 (0,25 µg/ml cip) ✓ - 8 
5 5 (0,25 µg/ml cip) ✓ - 8 
6 6 (0,25 µg/ml cip) ✓ - 8 
Double mutants: Trimethoprim + Ciprofloxacin, K56-41 
TP K56-41 MIC: 80%: 0,012 µg/ml ciprofloxacin 
No. Mutants 
(AB concentration) 
PCR E-test (MIC µg/ml) Growth cycle 
(Steps) 
1 1 (0,1 µg/ml cip) ✓ - 8 
2 2 (0,1 µg/ml cip) ✓ - 8 
3 3 (0,1 µg/ml cip) ✓ - 8 
4 4 (0,1 µg/ml cip) ✓ - 8 
5 5 (0,1 µg/ml cip) ✓ - 8 
6 6 (0,1 µg/ml cip) ✓ - 8 







Table I: TP+CIP78 mutants isolated in this study 
 Double mutants: Trimethoprim + Ciprofloxacin, K56-78 
TP K56-78 MIC: 0,016 µg/ml ciprofloxacin 
No. Mutants 
(AB concentration) 
PCR E-test (MIC µg/ml) Growth cycle 
(Steps) 
1 1 (0,25 µg/ml) ✓ - 8 
2 2 (0,25 µg/ml) ✓ - 8 
3 3 (0,25 µg/ml) ✓ TP: 8 
CIP: 0,38 
8 






Appendix 2: RAPD-fingerprints of single (CIP) and double (TP+CIP) mutants not 
presented in results.  
 
 
Figure A: PCR fingerprints of ten random CIP mutant isolates. L: SmartLadder, Lanes 1-10: E. 











Figure B: PCR fingerprints of double mutant isolates (TP+CIP22, 41 and 78). L: 
SmartLadder, Lanes 1-6 (TP+CIP22)/1-7(TP+CIP41)/1-4 (TP+CIP78): E. coli mutants, 






Appendix 3: Growth curve OD650 measurements of single and double mutants with their 
respective wild type strains. Average raw data was used to calculate generation time for 
each mutant and wild type strains.  
 
Table J: Average raw data of four biological replicates from OD650 growth curve readings of single 
mutant TP strains with the respective WT strains (technical parallel 1 and 2) 
 
  Average TP parallel 1                                                             Average TP parallel 2   
 Time          TP22         TP41                               
    
TP 78 WT 22 WT 41   WT 78                 Time         TP 22          TP41        TP 78 WT 22 WT 41 WT 78 
 01:20 0,001533 0,002033 0,004883 0,003358 0,002133 0,005183                01:20 0,002933 0,002783 0,005133 0,002783 0,003383 0,006308 
 01:40 0,004408 0,006583 0,013333 0,008983 0,007958 0,015258                01:40 0,006408 0,008283 0,013358 0,008383 0,009808 0,016258 
 02:00 0,008867 0,016292 0,031567 0,020242 0,020267 0,037692                02:00 0,011542 0,019692 0,031567 0,020217 0,023242 0,038592 
 02:20 0,014333 0,037483 0,070908 0,045183 0,046458 0,085958                02:20 0,018383 0,044258 0,070033 0,045358 0,052058 0,087108 
 02:40 0,019992 0,081242 0,140992 0,095117 0,100517 0,154792                02:40 0,025017 0,094917 0,138942 0,096142 0,111117 0,156592 
 03:00 0,027258 0,145408 0,232558 0,158483 0,162108 0,264733                03:00 0,035058 0,157333 0,226758 0,158708 0,172833 0,266858 
 03:20 0,035967 0,241367 0,384392 0,269192 0,278517 0,431042                03:20 0,049717 0,265467 0,376017 0,269392 0,295067 0,434617 
 03:40 0,051067 0,389842 0,525467 0,415617 0,430442 0,578567                03:40 0,073667 0,417492 0,512842 0,414792 0,445067 0,580617 
 04:00 0,078042 0,534692 0,643392 0,543642 0,555942 0,687042                04:00 0,108017 0,546142 0,631892 0,540492 0,562592 0,689042 
 04:20 0,121967 0,643742 0,749692 0,644017 0,671042 0,785942                04:20 0,163317 0,657592 0,738867 0,641992 0,677467 0,789217 
 04:40 0,190175 0,72365 0,826825 0,72205 0,74215 0,8558                 04:40 0,248225 0,729325 0,81775 0,722475 0,750175 0,86125 
 05:00 0,2854 0,7856 0,885875 0,772075 0,806575 0,911375                05:00 0,361675 0,794175 0,878175 0,775425 0,815125 0,917125 
 05:20 0,380017 0,842292 0,932692 0,822067 0,863792 0,958817                05:20 0,460792 0,851842 0,927242 0,826667 0,872342 0,965867 
 05:40 0,480667 0,891192 0,970717 0,862917 0,911867 1,000917                05:40 0,549092 0,899767 0,966392 0,869417 0,920967 1,009667 
 06:00 0,563208 0,935733 1,009083 0,901208 0,957183 1,040258                06:00 0,633433 0,944433 1,005783 0,908583 0,966458 1,049933 
 06:20 0,601367 0,977592 1,039692 0,937992 0,994667 1,069167                06:20 0,663742 0,986817 1,040567 0,946692 1,005017 1,080742 
 06:40 0,640908 1,007783 1,059883 0,974283 1,022608 1,093983                06:40 0,693383 1,017983 1,064083 0,985508 1,034883 1,106858 
 07:00 0,655175 1,0345 1,07555 1,00075 1,048125 1,111475                07:00 0,6963 1,045825 1,08095 1,01375 1,061075 1,12525 
 07:20 0,688958 1,060433 1,086283 1,022333 1,071208 1,125383                07:20 0,734808 1,073458 1,093333 1,036308 1,084533 1,139183 
 07:40 0,717208 1,075258 1,094483 1,039133 1,079958 1,134433                07:40 0,760483 1,091208 1,103733 1,054308 1,093708 1,149708 
 08:00 0,744625 1,078975 1,099875 1,050975 1,078 1,138275                08:00 0,783275 1,09575 1,111325 1,067875 1,0935 1,1553 
 08:20 0,775275 1,0753 1,1037 1,06025 1,073125 1,140675                08:20 0,8222 1,09325 1,116025 1,07865 1,09005 1,158 
 08:40 0,798292 1,070217 1,106792 1,067742 1,067142 1,139967                08:40 0,836142 1,089867 1,120042 1,086492 1,085567 1,157867 
 09:00 0,8164 1,065525 1,108625 1,0737 1,06195 1,137675                09:00 0,8515 1,0861 1,123025 1,0932 1,08055 1,1571 
 09:20 0,840592 1,059092 1,108967 1,075392 1,055867 1,135792                09:20 0,873467 1,080017 1,124567 1,095417 1,073617 1,155717 
 09:40 0,84515 1,054375 1,1096 1,07575 1,0502 1,13315                 09:40 0,8822 1,0735 1,1257 1,095625 1,067175 1,153025 
 10:00 0,852767 1,047592 1,109192 1,073992 1,043167 1,129842                10:00 0,892992 1,067142 1,126217 1,094717 1,060817 1,150442 
 10:20 0,864575 1,04085 1,1086 1,0724 1,0356 1,125775                10:20 0,90825 1,061675 1,12665 1,0942 1,054525 1,147775 
 10:40 0,86775 1,034 1,107275 1,069175 1,028175 1,1227                 10:40 0,9118 1,055 1,125575 1,09115 1,04865 1,1435 
 11:00 0,876358 1,027308 1,105558 1,066558 1,019233 1,118508                11:00 0,922758 1,049108 1,124608 1,089883 1,041833 1,140483 
 11:20 0,877792 1,019642 1,103142 1,063417 1,009517 1,114967                11:20 0,928267 1,042592 1,123167 1,087767 1,034017 1,137192 
 11:40 0,885775 1,011625 1,101275 1,060725 1,000175 1,111675                11:40 0,937075 1,0364 1,121825 1,0853 1,026825 1,13465 
 12:00 0,888717 1,002517 1,097992 1,057417 0,989817 1,107542                12:00 0,940942 1,028892 1,119642 1,082667 1,018042 1,131167 
 12:20 0,888433 0,993283 1,095083 1,054208 0,980408 1,104133                12:20 0,942433 1,021283 1,117608 1,079608 1,011133 1,128008 
 12:40 0,887692 0,983792 1,092517 1,050492 0,970892 1,101017                12:40 0,943792 1,013492 1,115367 1,076792 1,003367 1,125542 
 13:00 0,89005 0,974525 1,090425 1,048375 0,96275 1,09775                 13:00 0,947025 1,0063 1,1141 1,075525 0,9963 1,123075 
 13:20 0,892408 0,965108 1,088008 1,044508 0,953683 1,095033                13:20 0,950033 0,997808 1,112108 1,072158 0,989233 1,120933 
 13:40 0,89585 0,955775 1,0853 1,04185 0,94565 1,0924                 13:40 0,952425 0,98915 1,109275 1,0697 0,982575 1,1179 
 14:00 0,896975 0,9463 1,082225 1,03915 0,937175 1,0888                 14:00 0,953425 0,98155 1,106975 1,066925 0,9753 1,11525 
 14:20 0,890342 0,937442 1,079892 1,036017 0,929817 1,086242                14:20 0,949342 0,973292 1,104842 1,064667 0,968892 1,112917 
 14:40 0,890383 0,929783 1,077508 1,033758 0,923133 1,084108                14:40 0,950858 0,965733 1,102608 1,062458 0,962608 1,110783 
 15:00 0,88875 0,92105 1,074975 1,030925 0,91635 1,08135                 15:00 0,94955 0,95805 1,100125 1,060325 0,956525 1,10845 
 15:20 0,887108 0,913783 1,072533 1,027958 0,910233 1,078808                15:20 0,947883 0,950533 1,098033 1,057708 0,950683 1,105933 
 15:40 0,888417 0,906967 1,070967 1,025342 0,905167 1,076817                15:40 0,950842 0,943417 1,096167 1,055242 0,945517 1,103817 
 16:00 0,891058 0,899933 1,067783 1,022708 0,899658 1,073133                16:00 0,952208 0,936683 1,093758 1,053608 0,940258 1,101408 
 16:20 0,889408 0,894233 1,064933 1,020183 0,895083 1,071733                16:20 0,951283 0,930308 1,091333 1,051583 0,935158 1,099858 
 16:40 0,881742 0,888542 1,062692 1,017642 0,890367 1,068517                16:40 0,946367 0,924267 1,089117 1,049417 0,930667 1,097742 
 17:00 0,882792 0,883617 1,060442 1,015492 0,886542 1,066592                17:00 0,946967 0,919217 1,086667 1,047367 0,926742 1,095917 
 17:20 0,883075 0,879275 1,0577 1,013 0,8834 1,0643                 17:20 0,946175 0,914 1,084325 1,045075 0,9226 1,09335 
 17:40 0,885483 0,875783 1,055258 1,010408 0,880683 1,062833                17:40 0,947633 0,909283 1,081208 1,042683 0,919083 1,092058 
 18:00 0,882883 0,871633 1,052683 1,008433 0,877983 1,060058                18:00 0,945483 0,905208 1,078683 1,041358 0,915633 1,089983 
 18:20 0,875058 0,868283 1,050283 1,005758 0,874833 1,057708                18:20 0,941708 0,901733 1,077108 1,040133 0,913183 1,087983 
 18:40 0,881042 0,865492 1,047742 1,003767 0,872842 1,055842                18:40 0,943817 0,897742 1,074117 1,037342 0,909817 1,086192 
 19:00 0,8789 0,862775 1,045925 1,0018 0,870675 1,053475                19:00 0,94365 0,894875 1,0721 1,035875 0,907075 1,0848 
 19:20 0,8782 0,86025 1,0433 0,999025 0,8686 1,051225                19:20 0,942625 0,89165 1,069225 1,033725 0,904875 1,08245 
 19:40 0,875833 0,857858 1,040808 0,996883 0,867033 1,049658                19:40 0,941558 0,889033 1,066808 1,032008 0,902758 1,081408 
 20:00 0,868175 0,855725 1,03975 0,994625 0,86555 1,047325                20:00 0,9373 0,885875 1,06475 1,029875 0,900175 1,07885 
 20:20 0,8744 0,8537 1,0375 0,992875 0,864075 1,04645                 20:20 0,939175 0,88365 1,061875 1,02795 0,898275 1,07715 
 20:40 0,872583 0,851808 1,035233 0,990158 0,862208 1,043858                20:40 0,938783 0,881158 1,059658 1,026433 0,896083 1,075158 
 21:00 0,871358 0,850108 1,033358 0,988158 0,860908 1,042858                21:00 0,936408 0,878658 1,057408 1,024033 0,894008 1,074183 
 21:20 0,86155 0,848275 1,031425 0,985925 0,8599 1,04045                 21:20 0,9334 0,87655 1,0554 1,02245 0,8926 1,072425 
 21:40 0,863625 0,84695 1,029725 0,984025 0,858475 1,038775                21:40 0,933625 0,87505 1,053575 1,020525 0,89085 1,0711 
 22:00 0,86705 0,84545 1,027775 0,9822 0,857575 1,03715                 22:00 0,934825 0,87305 1,05145 1,018625 0,889 1,0691 
 22:20 0,864408 0,843658 1,025808 0,979383 0,856108 1,034483                22:20 0,932958 0,871783 1,050508 1,017958 0,887758 1,068058 
 22:40 0,858567 0,842592 1,024667 0,977542 0,855642 1,033167                22:40 0,930492 0,869517 1,047592 1,015067 0,886617 1,065017 






Table K: Average raw data of four biological replicates from OD650 growth curve readings of single 
mutant TP strains with the respective WT strains (technical parallel 3 and 4) 
  Average TP parallel 3     Average TP parallel 4  
 Time       TP 22               TP 41 TP 78 WT 22 WT 41 WT 78  Time       TP 22             TP 41 TP 78 WT 22 WT 41 WT 78 
 01:20 0,00445 0,003825 0,0065 0,00555 0,003025 0,005775  01:20 0,00275 0,00285 0,0051 0,00495 0,003875 0,006975 
 01:40 0,007325 0,007925 0,013275 0,0106 0,00645 0,012725  01:40 0,004575 0,006075 0,0114 0,009725 0,007475 0,01495 
 02:00 0,0115 0,017025 0,028675 0,021775 0,0134 0,028875  02:00 0,0069 0,013075 0,025325 0,020125 0,0153 0,0329 
 02:20 0,016975 0,035875 0,0612 0,045575 0,028775 0,06395  02:20 0,0104 0,028 0,0551 0,04265 0,0315 0,071925 
 02:40 0,023 0,07625 0,1272 0,0946 0,060875 0,13275  02:40 0,014375 0,059275 0,115075 0,088525 0,0662 0,14415 
 03:00 0,030758 0,143133 0,200983 0,157033 0,127608 0,208058  03:00 0,019008 0,121583 0,181408 0,156858 0,135758 0,227058 
 03:20 0,0414 0,2259 0,342475 0,266275 0,19055 0,35805  03:20 0,024925 0,1853 0,3129 0,253925 0,199125 0,3808 
 03:40 0,055783 0,368983 0,482058 0,411808 0,323783 0,513708  03:40 0,031958 0,311033 0,450208 0,404983 0,334458 0,542408 
 04:00 0,0826 0,522675 0,6097 0,539825 0,476525 0,630125  04:00 0,042775 0,464125 0,5862 0,537025 0,485825 0,64985 
 04:20 0,12935 0,618725 0,71475 0,64045 0,579275 0,7381  04:20 0,06285 0,57275 0,68825 0,626325 0,5861 0,75395 
 04:40 0,195258 0,709433 0,794058 0,712833 0,685008 0,815958  04:40 0,099933 0,682633 0,772883 0,715083 0,693158 0,831458 
 05:00 0,287533 0,776333 0,854358 0,767258 0,751333 0,874883  05:00 0,159158 0,750783 0,837058 0,767208 0,760908 0,889533 
 05:20 0,389942 0,835467 0,902367 0,817792 0,813917 0,926692  05:20 0,240192 0,814717 0,888717 0,818517 0,822417 0,939167 
 05:40 0,478642 0,885917 0,942367 0,859817 0,865842 0,969992  05:40 0,336367 0,868042 0,928767 0,861167 0,874792 0,981992 
 06:00 0,5451 0,9317 0,9819 0,8986 0,91315 1,011575  06:00 0,427975 0,91705 0,96825 0,900775 0,923025 1,022325 
 06:20 0,603217 0,976017 1,013342 0,935667 0,958667 1,045892  06:20 0,538592 0,963167 1,000642 0,936342 0,968242 1,056692 
 06:40 0,62695 1,008925 1,033775 0,9732 0,992875 1,073325  06:40 0,5921 0,99915 1,02285 0,974375 1,003075 1,084225 
 07:00 0,652017 1,035217 1,050192 1,000817 1,019167 1,095642  07:00 0,633617 1,028592 1,040492 1,004217 1,030617 1,105542 
 07:20 0,678675 1,062925 1,060425 1,021275 1,04625 1,11105  07:20 0,64635 1,0535 1,05155 1,02645 1,0584 1,120775 
 07:40 0,7098 1,080275 1,067725 1,03585 1,065825 1,123225  07:40 0,665725 1,078825 1,060125 1,0436 1,0767 1,1333 
 08:00 0,740342 1,083217 1,073417 1,047817 1,067767 1,129817  08:00 0,702217 1,089667 1,065692 1,056292 1,078567 1,140267 
 08:20 0,7693 1,0791 1,07685 1,0571 1,063375 1,132475  08:20 0,735025 1,08825 1,0697 1,0659 1,075325 1,14255 
 08:40 0,794192 1,074267 1,079767 1,064242 1,058167 1,132792  08:40 0,759717 1,084942 1,074117 1,073442 1,070892 1,143992 
 09:00 0,815192 1,068692 1,081567 1,068142 1,052192 1,131242  09:00 0,805542 1,079742 1,076542 1,077817 1,065367 1,143367 
 09:20 0,829267 1,062492 1,082967 1,070017 1,045917 1,128742  09:20 0,831417 1,072117 1,078917 1,079517 1,058642 1,141142 
 09:40 0,833517 1,055942 1,083792 1,069767 1,039442 1,125642  09:40 0,840167 1,064767 1,081067 1,079267 1,051867 1,138242 
 10:00 0,841108 1,049208 1,083633 1,067958 1,032858 1,122483  10:00 0,853583 1,057458 1,081633 1,078083 1,044933 1,136183 
 10:20 0,853292 1,041867 1,082692 1,065542 1,025967 1,119217  10:20 0,868617 1,050167 1,082067 1,076367 1,038217 1,132817 
 10:40 0,853317 1,035142 1,082092 1,063242 1,018567 1,115417  10:40 0,872267 1,044167 1,081067 1,074092 1,031342 1,129367 
 11:00 0,852808 1,028208 1,080458 1,060633 1,010233 1,111733  11:00 0,872683 1,037408 1,080108 1,071683 1,024758 1,125983 
 11:20 0,860308 1,021108 1,078008 1,057508 1,000458 1,108258  11:20 0,881958 1,031208 1,078783 1,069758 1,017483 1,122433 
 11:40 0,858092 1,014192 1,076767 1,055117 0,990567 1,104842  11:40 0,881467 1,024967 1,077767 1,067267 1,009792 1,118467 
 12:00 0,860475 1,005975 1,074275 1,051625 0,9793 1,10145  12:00 0,884275 1,0186 1,076175 1,064575 1,001725 1,1154 
 12:20 0,864017 0,997717 1,072117 1,048817 0,968692 1,098242  12:20 0,887867 1,011942 1,074267 1,061942 0,993867 1,111717 
 12:40 0,870375 0,989525 1,0697 1,04625 0,957925 1,095175  12:40 0,8965 1,00535 1,072675 1,06015 0,985875 1,1093 
 13:00 0,866425 0,980675 1,06725 1,043325 0,947825 1,092275  13:00 0,8904 0,998625 1,070225 1,057325 0,978075 1,10575 
 13:20 0,876817 0,971517 1,065092 1,040417 0,937842 1,089292  13:20 0,900642 0,991992 1,068517 1,055267 0,970742 1,103192 
 13:40 0,865683 0,963858 1,063108 1,037708 0,928858 1,086383  13:40 0,892483 0,985258 1,066483 1,053133 0,963658 1,099783 
 14:00 0,867183 0,955433 1,061008 1,035433 0,920008 1,083658  14:00 0,896333 0,978733 1,064658 1,050758 0,956133 1,097258 
 14:20 0,869283 0,947683 1,058933 1,032783 0,912208 1,080733  14:20 0,900858 0,972108 1,062983 1,048808 0,949733 1,094333 
 14:40 0,86245 0,93955 1,056825 1,03015 0,90465 1,078325  14:40 0,8939 0,965625 1,061025 1,0466 0,943275 1,0914 
 15:00 0,862217 0,932417 1,054367 1,028167 0,897567 1,075717  15:00 0,896867 0,960142 1,059692 1,044892 0,937042 1,089192 
 15:20 0,861633 0,924583 1,052333 1,025158 0,891108 1,072908  15:20 0,895533 0,953683 1,057783 1,042808 0,931208 1,086308 
 15:40 0,86755 0,9173 1,050425 1,0227 0,885875 1,070225  15:40 0,901475 0,947325 1,055575 1,0408 0,925325 1,084575 
 16:00 0,854775 0,91035 1,048025 1,02065 0,88045 1,067425  16:00 0,8891 0,941975 1,0544 1,03925 0,9201 1,0825 
 16:20 0,859142 0,903842 1,046567 1,018092 0,876042 1,064917  16:20 0,895467 0,935942 1,052242 1,036942 0,915142 1,079417 
 16:40 0,8562 0,897675 1,044475 1,015825 0,872375 1,062525  16:40 0,8931 0,930275 1,050725 1,034675 0,9105 1,076975 
 17:00 0,8487 0,89215 1,042175 1,01355 0,868475 1,059725  17:00 0,88525 0,9248 1,048825 1,033125 0,9063 1,074975 
 17:20 0,858217 0,886067 1,040342 1,011442 0,865492 1,057392  17:20 0,894942 0,919692 1,047567 1,031567 0,902642 1,072967 
 17:40 0,855675 0,88135 1,03925 1,009325 0,8627 1,05535  17:40 0,893225 0,91465 1,0455 1,0296 0,8983 1,070425 
 18:00 0,847183 0,876658 1,036658 1,006933 0,860008 1,052383  18:00 0,886433 0,910208 1,044558 1,028708 0,895558 1,069208 
 18:20 0,841775 0,872525 1,0345 1,004925 0,85765 1,04995  18:20 0,882175 0,90575 1,04285 1,026825 0,891925 1,0672 
 18:40 0,841608 0,868658 1,033058 1,003008 0,856158 1,047958  18:40 0,882258 0,901083 1,040858 1,024958 0,888808 1,064558 
 19:00 0,834075 0,865 1,031 1,0009 0,85375 1,04465  19:00 0,874925 0,89695 1,03995 1,0239 0,8861 1,063125 
 19:20 0,8444 0,862 1,029475 0,998825 0,852625 1,04275  19:20 0,883975 0,892825 1,03795 1,022 0,883025 1,060225 
 19:40 0,8353 0,8591 1,027225 0,99645 0,85065 1,03975  19:40 0,8783 0,889575 1,036875 1,02065 0,880625 1,05895 
 20:00 0,826358 0,856358 1,025158 0,994608 0,848858 1,037258  20:00 0,870233 0,886058 1,035408 1,019308 0,878108 1,056533 
 20:20 0,829692 0,854192 1,023942 0,993217 0,848267 1,035242  20:20 0,873417 0,882467 1,034292 1,018042 0,875717 1,054917 
 20:40 0,82755 0,85185 1,02235 0,991425 0,846875 1,032975  20:40 0,8726 0,879625 1,0334 1,0171 0,873625 1,0533 
 21:00 0,822475 0,849775 1,02 0,9888 0,845225 1,030925  21:00 0,8685 0,876675 1,03165 1,0156 0,871525 1,0519 
 21:20 0,818758 0,847958 1,018283 0,986933 0,844033 1,028708  21:20 0,865133 0,874083 1,030758 1,013983 0,869858 1,050283 
 21:40 0,8131 0,84625 1,01675 0,984575 0,842525 1,026025  21:40 0,857425 0,871225 1,029325 1,012525 0,867825 1,048175 
 22:00 0,816842 0,845017 1,015592 0,982717 0,841692 1,023417  22:00 0,863617 0,868742 1,027992 1,011217 0,865592 1,045642 








Table L: Average raw data of four biological replicates from OD650 growth curve readings of single 
mutant CIP strains with the respective WT strains (technical parallel 1 and 2) 
    Average CIP parallel 1     Average CIP parallel 2  
 Time CIP 22 CIP 41 CIP 78 WT 22 WT 41 WT 78  Time    CIP 22               CIP 41 CIP 78 WT 22           WT 41 WT 78 
 01:20 0,006742 0,005992 0,007742 0,005217 0,004642 0,008367  01:20 0,004267 0,003642 0,007267 0,004842 0,003942 0,007092 
 01:40 0,012875 0,012925 0,01695 0,010675 0,009825 0,01845  01:40 0,008975 0,009175 0,016225 0,010875 0,009325 0,01645 
 02:00 0,025592 0,027467 0,037067 0,022217 0,021192 0,041392  02:00 0,018917 0,021042 0,035917 0,023567 0,021092 0,037717 
 02:20 0,052192 0,058492 0,079642 0,046692 0,045392 0,088867  02:20 0,039942 0,045767 0,077842 0,050192 0,045767 0,081692 
 02:40 0,102508 0,113433 0,134258 0,093358 0,092183 0,144883  02:40 0,081583 0,094508 0,133058 0,100033 0,093658 0,137733 
 03:00 0,162125 0,175 0,23325 0,150675 0,144325 0,256075  03:00 0,137875 0,145025 0,229225 0,158525 0,145225 0,241475 
 03:20 0,27715 0,299925 0,379 0,25845 0,25035 0,42525  03:20 0,2341 0,2525 0,37385 0,270875 0,25095 0,40765 
 03:40 0,438175 0,445325 0,535175 0,4132 0,3997 0,582225  03:40 0,38565 0,401825 0,5294 0,429325 0,40065 0,574725 
 04:00 0,566467 0,559792 0,639492 0,546942 0,530967 0,690742  04:00 0,534492 0,529017 0,629017 0,550992 0,531567 0,675242 
 04:20 0,674208 0,668508 0,734083 0,651258 0,646583 0,778158  04:20 0,625558 0,642833 0,729183 0,657808 0,650433 0,774933 
 04:40 0,739692 0,732617 0,796592 0,719392 0,715992 0,838117  04:40 0,723517 0,713417 0,791892 0,725567 0,721692 0,837967 
 05:00 0,791725 0,789625 0,848625 0,77315 0,7761 0,890575  05:00 0,7781 0,774325 0,845125 0,781975 0,784925 0,893025 
 05:20 0,839975 0,8317 0,891725 0,821675 0,82415 0,924775  05:20 0,827525 0,8241 0,892475 0,83475 0,835475 0,933425 
 05:40 0,882517 0,859092 0,921067 0,867417 0,855517 0,952592  05:40 0,874967 0,855267 0,922292 0,881217 0,868792 0,964892 
 06:00 0,924483 0,881958 0,947158 0,913083 0,877808 0,976333  06:00 0,918808 0,879933 0,948783 0,937633 0,891908 0,990458 
 06:20 0,962483 0,897808 0,971333 0,956633 0,892533 0,997983  06:20 0,960158 0,896858 0,975558 0,979108 0,907058 1,015433 
 06:40 0,9926 0,9103 0,997775 0,98925 0,909975 1,019025  06:40 0,99415 0,907675 1,000575 1,012575 0,922375 1,0354 
 07:00 1,018058 0,933108 1,019808 1,015908 0,924083 1,033383  07:00 1,022633 0,932408 1,025808 1,040008 0,939608 1,053133 
 07:20 1,039075 0,9521 1,039275 1,037 0,941875 1,04435  07:20 1,0475 0,951525 1,047625 1,062525 0,9562 1,066375 
 07:40 1,056158 0,969008 1,056558 1,056933 0,960808 1,058058  07:40 1,065958 0,968008 1,066533 1,084758 0,974958 1,080358 
 08:00 1,072175 0,978825 1,067925 1,070475 0,97525 1,0654  08:00 1,0822 0,985175 1,078425 1,102075 0,99295 1,08945 
 08:20 1,088383 0,946008 1,070108 1,077758 0,944033 1,065683  08:20 1,098783 0,977458 1,083658 1,112108 0,985533 1,089783 
 08:40 1,097525 0,9201 1,068975 1,0832 0,914225 1,060175  08:40 1,111625 0,946475 1,08425 1,115325 0,951325 1,08815 
 09:00 1,102367 0,904267 1,066217 1,085742 0,897342 1,052717  09:00 1,117942 0,924342 1,082992 1,112342 0,929567 1,080342 
 09:20 1,103425 0,8959 1,06165 1,0874 0,888175 1,04515  09:20 1,120525 0,91265 1,0808 1,107825 0,917775 1,07225 
 09:40 1,102733 0,889308 1,055833 1,086283 0,881283 1,038808  09:40 1,120408 0,904808 1,073158 1,102658 0,910408 1,065983 
 10:00 1,100167 0,883192 1,048017 1,085492 0,874692 1,032817  10:00 1,119692 0,899517 1,067167 1,098067 0,904592 1,060042 
 10:20 1,097517 0,875992 1,042017 1,082592 0,867817 1,027117  10:20 1,118017 0,893842 1,060667 1,094192 0,898992 1,054642 
 10:40 1,093267 0,867492 1,036692 1,079617 0,859967 1,019442  10:40 1,115667 0,888392 1,054167 1,090767 0,893017 1,049117 
 11:00 1,090042 0,859892 1,031292 1,076467 0,852617 1,012942  11:00 1,112917 0,882042 1,050142 1,087167 0,886892 1,042967 
 11:20 1,08585 0,852125 1,025625 1,073475 0,84555 1,006575  11:20 1,110025 0,875325 1,045275 1,0837 0,880475 1,0381 
 11:40 1,081383 0,845458 1,019783 1,069708 0,839058 1,000033  11:40 1,107108 0,869308 1,041158 1,081658 0,874558 1,032558 
 12:00 1,076867 0,838617 1,013742 1,065017 0,833117 0,994842  12:00 1,103992 0,862917 1,035592 1,078392 0,868667 1,027042 
 12:20 1,0728 0,8322 1,008075 1,06115 0,827075 0,990025  12:20 1,101 0,85725 1,030525 1,075375 0,863425 1,021975 
 12:40 1,068458 0,824658 1,003083 1,056983 0,820033 0,984408  12:40 1,097883 0,851458 1,025408 1,072408 0,857858 1,017233 
 13:00 1,064383 0,818058 0,997908 1,052883 0,813233 0,979508  13:00 1,095158 0,844883 1,020033 1,069208 0,852033 1,013433 
 13:20 1,060275 0,8119 0,9926 1,0482 0,8073 0,973975  13:20 1,091925 0,838825 1,014725 1,066225 0,84595 1,0088 
 13:40 1,05615 0,8069 0,9883 1,04465 0,8021 0,96925  13:40 1,089325 0,8337 1,01015 1,0633 0,840975 1,00525 
 14:00 1,05215 0,802225 0,98365 1,0406 0,797925 0,964475  14:00 1,08585 0,8285 1,0047 1,06015 0,83575 1,000475 
 14:20 1,048075 0,7988 0,97885 1,036375 0,7943 0,9593  14:20 1,0827 0,824875 1,000325 1,05775 0,83195 0,996275 
 14:40 1,044208 0,795533 0,974758 1,032883 0,791158 0,954733  14:40 1,079558 0,821208 0,994958 1,054508 0,828383 0,990783 
 15:00 1,040367 0,791917 0,970567 1,029617 0,788242 0,950142  15:00 1,076367 0,817892 0,990892 1,051942 0,825267 0,986717 
 15:20 1,0361 0,7885 0,966575 1,0266 0,7848 0,945175  15:20 1,0735 0,814725 0,98735 1,050375 0,823 0,983525 
 15:40 1,032425 0,784925 0,962475 1,0234 0,781525 0,94175  15:40 1,070175 0,81075 0,982775 1,0468 0,819475 0,979325 
 16:00 1,028675 0,7821 0,959075 1,02055 0,778425 0,93725  16:00 1,06765 0,807825 0,97955 1,0451 0,8173 0,9753 
 16:20 1,025617 0,779417 0,955942 1,018317 0,776317 0,933292  16:20 1,064842 0,804567 0,976017 1,043417 0,814292 0,971742 
 16:40 1,021717 0,776817 0,952467 1,015267 0,773817 0,929967  16:40 1,061392 0,801792 0,971842 1,040492 0,811192 0,968042 
 17:00 1,018517 0,775217 0,949942 1,012667 0,772417 0,926442  17:00 1,058642 0,799317 0,968467 1,038017 0,808917 0,963867 
 17:20 1,015992 0,773267 0,947242 1,009742 0,770967 0,923467  17:20 1,055742 0,797442 0,964942 1,035592 0,807442 0,960567 
 17:40 1,012817 0,771217 0,944117 1,006542 0,768817 0,919317  17:40 1,053192 0,795667 0,962117 1,032967 0,806067 0,957692 
 18:00 1,009725 0,769825 0,942125 1,004475 0,767625 0,917025  18:00 1,05105 0,79415 0,959625 1,031375 0,80495 0,95485 
 18:20 1,0059 0,76725 0,938875 1,00125 0,765375 0,913475  18:20 1,048075 0,7923 0,95645 1,029225 0,80385 0,952025 
 18:40 1,003442 0,766192 0,936967 0,999442 0,764742 0,910867  18:40 1,045467 0,791067 0,954792 1,027642 0,803017 0,949167 
 19:00 1,000358 0,764833 0,934633 0,996283 0,762958 0,908083  19:00 1,043258 0,788983 0,951558 1,024558 0,801283 0,946408 
 19:20 0,997267 0,763567 0,932467 0,993842 0,761417 0,905242  19:20 1,040842 0,788417 0,950217 1,023542 0,800842 0,943742 
 19:40 0,994233 0,762283 0,930658 0,991308 0,760708 0,903558  19:40 1,037758 0,786433 0,946958 1,020508 0,799083 0,941233 
 20:00 0,991333 0,760608 0,928633 0,988808 0,759183 0,901008  20:00 1,035033 0,785183 0,944758 1,018333 0,797833 0,938833 
 20:20 0,98805 0,759825 0,926675 0,986125 0,75835 0,89875  20:20 1,03235 0,784075 0,9422 1,0166 0,797025 0,937025 
 20:40 0,98545 0,7584 0,925025 0,98375 0,757125 0,896075  20:40 1,03025 0,782825 0,939975 1,0141 0,79575 0,93445 
 21:00 0,982108 0,757233 0,922933 0,981208 0,756008 0,893833  21:00 1,027533 0,781983 0,938658 1,012433 0,794908 0,933333 
 21:20 0,9793 0,756875 0,921225 0,978775 0,7553 0,8922  21:20 1,025475 0,781325 0,936525 1,0104 0,79445 0,931075 
 21:40 0,976067 0,755292 0,919867 0,975842 0,754192 0,890117  21:40 1,022442 0,780017 0,934542 1,007767 0,793442 0,928867 









Table M: Average raw data of four biological replicates from OD650 growth curve readings of single 
mutant CIP strains with the respective WT strains (technical parallel 3 and 4) 
   Average CIP parallel 3   Average CIP parallel 4  
 Time                 CIP 
22 
CIP 41 CIP 78 WT 22          WT 41 WT 78  Time        CP22          CIP41              CIP 78 WT 22          WT 41 WT 78 
 01:20 0,00335 0,00115 0,0048 0,00445 0,0034 0,0044  01:20 0,003375 0,0015 0,00505 0,003725 0,0033 0,00475 
 01:40 0,007292 0,004867 0,010742 0,009267 0,007292 0,011342  01:40 0,006967 0,005617 0,011392 0,008167 0,006817 0,011417 
 02:00 0,014908 0,012633 0,024358 0,019583 0,015358 0,026683  02:00 0,014308 0,013458 0,025033 0,018058 0,014258 0,025858 
 02:20 0,030983 0,028783 0,054383 0,041308 0,032783 0,061658  02:20 0,029108 0,030883 0,056233 0,038933 0,030333 0,057683 
 02:40 0,06355 0,062925 0,1176 0,0868 0,068875 0,13135  02:40 0,06 0,066525 0,121475 0,082025 0,064125 0,123725 
 03:00 0,128725 0,129125 0,18575 0,154025 0,139175 0,209375  03:00 0,122475 0,13535 0,1913 0,15645 0,131775 0,1963 
 03:20 0,195533 0,196583 0,316783 0,251933 0,208333 0,359133  03:20 0,186983 0,202158 0,323608 0,243558 0,195258 0,337858 
 03:40 0,323558 0,333383 0,455558 0,402258 0,348008 0,517958  03:40 0,311708 0,338158 0,461083 0,395858 0,329883 0,494033 
 04:00 0,468258 0,482183 0,580958 0,533233 0,498333 0,639133  04:00 0,447433 0,483008 0,583358 0,528683 0,477683 0,623633 
 04:20 0,568575 0,5909 0,68745 0,6291 0,599925 0,748875  04:20 0,5618 0,58795 0,68885 0,620625 0,583475 0,73405 
 04:40 0,663833 0,700458 0,771683 0,717133 0,706558 0,828508  04:40 0,659908 0,697533 0,770708 0,718583 0,695458 0,819558 
 05:00 0,726375 0,7667 0,8296 0,77225 0,7724 0,884575  05:00 0,730375 0,763625 0,82675 0,77685 0,7638 0,8799 
 05:20 0,769067 0,828917 0,884117 0,823567 0,832867 0,934717  05:20 0,772392 0,824617 0,880592 0,828867 0,826142 0,931217 
 05:40 0,807883 0,881183 0,932008 0,867408 0,886408 0,978608  05:40 0,813083 0,876358 0,927658 0,875308 0,880058 0,977533 
 06:00 0,842183 0,927883 0,979083 0,906683 0,932858 1,019908  06:00 0,848183 0,923158 0,972558 0,915558 0,927983 1,019783 
 06:20 0,873142 0,969392 1,014317 0,942992 0,977042 1,051692  06:20 0,879767 0,966392 1,008442 0,952167 0,973217 1,054517 
 06:40 0,901908 1,008333 1,044133 0,980158 1,009258 1,077408  06:40 0,909433 1,003458 1,037583 0,989958 1,006908 1,081608 
 07:00 0,931267 1,035192 1,068217 1,008342 1,035067 1,097267  07:00 0,940117 1,030842 1,063667 1,018667 1,034192 1,103492 
 07:20 0,95115 1,061725 1,086175 1,03105 1,062175 1,1109  07:20 0,961125 1,057525 1,082 1,0415 1,0626 1,118225 
 07:40 0,965733 1,079008 1,099983 1,047683 1,076508 1,121133  07:40 0,976108 1,072758 1,095608 1,058983 1,077758 1,129983 
 08:00 0,97555 1,081325 1,10895 1,05955 1,074825 1,127025  08:00 0,987275 1,074725 1,106225 1,0705 1,077775 1,135575 
 08:20 0,983067 1,077367 1,114067 1,068692 1,069967 1,128742  08:20 0,995117 1,071792 1,111942 1,080742 1,074717 1,138492 
 08:40 0,9876 1,071875 1,116925 1,0751 1,064625 1,1288  08:40 1,0001 1,06705 1,116025 1,086525 1,06985 1,138775 
 09:00 0,991958 1,065508 1,117258 1,079133 1,058758 1,127033  09:00 1,004633 1,059633 1,115183 1,090008 1,063358 1,137608 
 09:20 0,993792 1,059192 1,115242 1,081167 1,052542 1,124392  09:20 1,006592 1,051967 1,114617 1,091342 1,056242 1,135492 
 09:40 0,993458 1,051858 1,112758 1,080908 1,045308 1,121408  09:40 1,006458 1,044208 1,112483 1,090083 1,049158 1,133683 
 10:00 0,990967 1,044042 1,110267 1,079417 1,037717 1,117667  10:00 1,004842 1,037017 1,110292 1,088392 1,041842 1,130967 
 10:20 0,98745 1,03605 1,1068 1,076925 1,029875 1,1137  10:20 1,00225 1,0293 1,1065 1,08525 1,0341 1,126525 
 10:40 0,983608 1,028158 1,104433 1,074433 1,020683 1,109933  10:40 0,999183 1,022583 1,104683 1,083333 1,026658 1,123783 
 11:00 0,978825 1,017675 1,100575 1,07055 1,008975 1,10535  11:00 0,9947 1,013875 1,1002 1,079275 1,01705 1,11955 
 11:20 0,9756 1,0072 1,098175 1,067825 0,997675 1,10155  11:20 0,991275 1,005975 1,0976 1,076425 1,0085 1,1159 
 11:40 0,971117 0,997392 1,095842 1,064967 0,986267 1,098067  11:40 0,987417 0,997767 1,094842 1,073567 0,999792 1,112692 
 12:00 0,966192 0,987067 1,092567 1,061742 0,975617 1,093717  12:00 0,983067 0,989142 1,091467 1,070042 0,990692 1,108842 
 12:20 0,961733 0,976958 1,090283 1,058433 0,964658 1,089958  12:20 0,978983 0,981433 1,089283 1,067058 0,981983 1,105508 
 12:40 0,956292 0,967742 1,087817 1,055067 0,954392 1,086192  12:40 0,974967 0,973592 1,086567 1,064392 0,973642 1,101867 
 13:00 0,951567 0,958817 1,085042 1,052417 0,945142 1,083092  13:00 0,970767 0,966367 1,083842 1,061642 0,965917 1,098742 
 13:20 0,946483 0,950858 1,082308 1,049233 0,935908 1,079733  13:20 0,966258 0,958958 1,081958 1,058908 0,957883 1,095583 
 13:40 0,94345 0,942975 1,0802 1,04645 0,928725 1,07705  13:40 0,9629 0,951975 1,07955 1,056325 0,95045 1,0931 
 14:00 0,938733 0,935358 1,077608 1,043283 0,920558 1,073433  14:00 0,959633 0,945683 1,077308 1,053608 0,943358 1,089333 
 14:20 0,933892 0,927892 1,074817 1,040667 0,913067 1,070492  14:20 0,955942 0,939192 1,075667 1,051617 0,936592 1,086742 
 14:40 0,929733 0,921358 1,073008 1,038233 0,906683 1,067633  14:40 0,952533 0,933583 1,073133 1,049033 0,929783 1,083683 
 15:00 0,925217 0,915292 1,069967 1,035842 0,900767 1,064942  15:00 0,947917 0,927567 1,070542 1,046692 0,923817 1,081042 
 15:20 0,92145 0,90955 1,0681 1,033275 0,8959 1,062  15:20 0,9444 0,9218 1,06935 1,044175 0,917825 1,0784 
 15:40 0,916508 0,904808 1,065983 1,031833 0,891408 1,060033  15:40 0,940258 0,917558 1,068808 1,043683 0,913333 1,077083 
 16:00 0,912342 0,899417 1,063742 1,029092 0,886767 1,056717  16:00 0,936417 0,911967 1,065842 1,040967 0,907867 1,073667 
 16:20 0,907542 0,895467 1,061517 1,026742 0,883242 1,054642  16:20 0,932092 0,907242 1,063667 1,038917 0,902792 1,071317 
 16:40 0,902833 0,891183 1,059433 1,024833 0,879658 1,052058  16:40 0,928783 0,902433 1,061808 1,037583 0,898758 1,068608 
 17:00 0,898267 0,887017 1,057117 1,022967 0,876217 1,049542  17:00 0,924842 0,898592 1,059992 1,036042 0,894942 1,066617 
 17:20 0,894592 0,884017 1,055392 1,021117 0,873942 1,047167  17:20 0,920417 0,893792 1,057967 1,034142 0,890867 1,063692 
 17:40 0,890667 0,880917 1,053242 1,019517 0,871842 1,044967  17:40 0,916567 0,890117 1,056692 1,032817 0,887292 1,060967 
 18:00 0,885608 0,877583 1,051058 1,017533 0,869183 1,042258  18:00 0,912983 0,886458 1,054683 1,031383 0,883933 1,058733 
 18:20 0,881842 0,875067 1,049117 1,015567 0,867717 1,040417  18:20 0,908517 0,882467 1,052842 1,029742 0,881042 1,056917 
 18:40 0,877875 0,872675 1,047525 1,013775 0,86585 1,038  18:40 0,9053 0,87895 1,05145 1,02855 0,878225 1,0545 
 19:00 0,873125 0,870475 1,0456 1,011925 0,86465 1,0361  19:00 0,901175 0,876175 1,050125 1,027175 0,87625 1,052225 
 19:20 0,868808 0,868008 1,043883 1,010408 0,862933 1,033558  19:20 0,897383 0,873158 1,049033 1,026408 0,873783 1,050558 
 19:40 0,864867 0,866342 1,041942 1,009242 0,861667 1,032517  19:40 0,893217 0,870467 1,047217 1,024667 0,871342 1,049017 
 20:00 0,860667 0,864692 1,040617 1,007792 0,860992 1,030317  20:00 0,888692 0,867417 1,045892 1,023567 0,869367 1,047667 
 20:20 0,85635 0,86295 1,038575 1,006375 0,8597 1,02825  20:20 0,8854 0,865475 1,044525 1,022325 0,867775 1,045375 
 20:40 0,851333 0,861258 1,036908 1,004383 0,858133 1,025808  20:40 0,880208 0,863008 1,043233 1,021083 0,866058 1,043733 
 21:00 0,8471 0,860225 1,0354 1,002825 0,857525 1,023975  21:00 0,87625 0,860825 1,0419 1,020125 0,864225 1,041575 
 21:20 0,843633 0,859108 1,034458 1,001758 0,857058 1,022908  21:20 0,871883 0,858358 1,040258 1,018558 0,862833 1,040108 
 21:40 0,838658 0,857683 1,032858 0,999858 0,855783 1,020108  21:40 0,867383 0,857083 1,039633 1,017458 0,861958 1,038208 
 22:00 0,8342 0,856925 1,031575 0,998225 0,8552 1,018825  22:00 0,8626 0,855125 1,038175 1,0162 0,8603 1,0358 











Table N: Average raw data of four biological replicates from OD650 growth curve readings of double 
mutant TP+CIP strains with the respective WT strains (technical parallel 1 and 2) 
 Average TP+CIP parallel 1  Average TP+CIP parallel 2  
 Time   CIP+TP 22   CIP+TP 41 CIP+TP 78 WT 22 WT 41           WT 78 Time    CIP+TP 22  CIP+TP 41 CIP+TP 78 WT 22 WT 41 WT 78 
 01:20 0,008883 0,008033 0,008183 0,006308 0,004233 0,008783 01:20 0,006733 0,005233 0,008508 0,005933 0,005733 0,009558 
 01:40 0,016992 0,016417 0,014617 0,012467 0,008642 0,019267 01:40 0,012867 0,011617 0,015192 0,011467 0,009917 0,020467 
 02:00 0,035017 0,035692 0,029817 0,025267 0,018167 0,043467 02:00 0,026042 0,025267 0,029642 0,022267 0,018342 0,045492 
 02:20 0,074992 0,078217 0,060842 0,052592 0,038392 0,096317 02:20 0,055442 0,056467 0,060642 0,046392 0,037042 0,099867 
 02:40 0,151875 0,150925 0,1253 0,108475 0,08095 0,16955 02:40 0,119475 0,12085 0,123875 0,094125 0,07535 0,17375 
 03:00 0,238208 0,250533 0,201158 0,174683 0,152283 0,289533 03:00 0,192533 0,193958 0,196008 0,163658 0,150508 0,295633 
 03:20 0,386042 0,413317 0,339592 0,295567 0,238617 0,458267 03:20 0,330192 0,332242 0,328567 0,264242 0,220417 0,464267 
 03:40 0,54595 0,579625 0,4821 0,443775 0,38905 0,61075 03:40 0,482225 0,494825 0,469 0,416475 0,366725 0,614825 
 04:00 0,649625 0,677675 0,6185 0,5658 0,543725 0,71495 04:00 0,61255 0,6244 0,6072 0,546325 0,528225 0,719625 
 04:20 0,7503 0,78575 0,72165 0,664925 0,641725 0,813575 04:20 0,71515 0,730125 0,71005 0,641775 0,62115 0,818025 
 04:40 0,817367 0,856067 0,805692 0,731142 0,733467 0,881392 04:40 0,799642 0,819017 0,797117 0,728917 0,725242 0,885567 
 05:00 0,868975 0,91305 0,868725 0,784 0,797625 0,937125 05:00 0,8569 0,87925 0,8626 0,781675 0,7897 0,9419 
 05:20 0,917283 0,962683 0,919483 0,833533 0,856958 0,984983 05:20 0,910608 0,934808 0,914758 0,831458 0,852108 0,989408 
 05:40 0,956717 1,005392 0,959667 0,875492 0,906217 1,026292 05:40 0,955067 0,981792 0,955867 0,875867 0,904267 1,031017 
 06:00 0,992525 1,043275 0,997575 0,914625 0,95075 1,0657 06:00 0,993825 1,022675 0,99475 0,915375 0,949775 1,0706 
 06:20 1,026792 1,079167 1,032217 0,953042 0,993417 1,095717 06:20 1,031192 1,062392 1,032542 0,953692 0,992442 1,100642 
 06:40 1,054458 1,106233 1,052483 0,989858 1,024608 1,118983 06:40 1,061633 1,092708 1,054833 0,992208 1,028158 1,124758 
 07:00 1,076942 1,127642 1,067217 1,017392 1,050942 1,138667 07:00 1,086392 1,118342 1,071467 1,020867 1,056467 1,144892 
 07:20 1,093658 1,144758 1,078033 1,038558 1,076033 1,153758 07:20 1,107458 1,139283 1,084183 1,042558 1,080608 1,160008 
 07:40 1,105383 1,155983 1,086308 1,055958 1,093008 1,164183 07:40 1,122333 1,155108 1,093758 1,058958 1,102983 1,171133 
 08:00 1,112617 1,162517 1,091592 1,069167 1,095267 1,170342 08:00 1,132742 1,164342 1,100817 1,072317 1,111917 1,177717 
 08:20 1,11625 1,165225 1,09525 1,079625 1,0904 1,1713 08:20 1,139525 1,170175 1,105675 1,083325 1,109625 1,179575 
 08:40 1,11755 1,1649 1,0975 1,08675 1,085275 1,171425 08:40 1,143025 1,17175 1,1094 1,091975 1,10555 1,18005 
 09:00 1,116533 1,164008 1,098633 1,091658 1,079408 1,169858 09:00 1,143583 1,171308 1,111833 1,097033 1,100958 1,179158 
 09:20 1,113792 1,161867 1,099817 1,092767 1,073867 1,168717 09:20 1,142117 1,169742 1,113642 1,098617 1,095417 1,177267 
 09:40 1,110392 1,159667 1,100042 1,092142 1,067667 1,165117 09:40 1,139617 1,168092 1,115192 1,099217 1,088917 1,174817 
 10:00 1,106725 1,156875 1,098925 1,09035 1,06185 1,1626 10:00 1,136725 1,1658 1,11515 1,098425 1,082575 1,171925 
 10:20 1,102617 1,154067 1,097967 1,087967 1,054717 1,159142 10:20 1,133342 1,162917 1,114917 1,096992 1,075767 1,168617 
 10:40 1,098125 1,15085 1,095675 1,085225 1,045775 1,1556 10:40 1,1303 1,16045 1,11435 1,09585 1,069225 1,165575 
 11:00 1,094092 1,147867 1,093817 1,082267 1,035492 1,151967 11:00 1,126292 1,157492 1,113067 1,093942 1,061667 1,162667 
 11:20 1,090525 1,1441 1,091975 1,0793 1,024375 1,14975 11:20 1,123125 1,1538 1,1109 1,091325 1,053625 1,1594 
 11:40 1,087033 1,140683 1,089583 1,076208 1,012383 1,146408 11:40 1,119808 1,150233 1,108683 1,088908 1,044633 1,156458 
 12:00 1,082508 1,137683 1,086633 1,073033 1,000658 1,143958 12:00 1,116933 1,148058 1,107583 1,086783 1,036783 1,153983 
 12:20 1,079575 1,13435 1,084175 1,070525 0,989975 1,141025 12:20 1,113975 1,1445 1,10575 1,084225 1,027775 1,151575 
 12:40 1,076658 1,130758 1,081733 1,066708 0,979058 1,138933 12:40 1,110958 1,140858 1,102108 1,081733 1,019283 1,148508 
 13:00 1,07355 1,127625 1,078875 1,064375 0,968425 1,135925 13:00 1,107875 1,13765 1,1004 1,07945 1,01145 1,1461 
 13:20 1,070617 1,123792 1,076792 1,061242 0,959067 1,133592 13:20 1,104842 1,134217 1,097817 1,076292 1,003342 1,142917 
 13:40 1,067883 1,120258 1,073558 1,058433 0,949733 1,130108 13:40 1,102083 1,131258 1,095083 1,073958 0,995658 1,140533 
 14:00 1,065175 1,117 1,070675 1,055225 0,940725 1,12745 14:00 1,09955 1,128375 1,092625 1,07115 0,988575 1,1382 
 14:20 1,062367 1,113617 1,067667 1,052617 0,932992 1,125892 14:20 1,096892 1,125392 1,090267 1,068592 0,981367 1,135892 
 14:40 1,058825 1,10915 1,063975 1,0487 0,9251 1,122875 14:40 1,0944 1,121775 1,087375 1,06635 0,9745 1,1339 
 15:00 1,056408 1,105283 1,060633 1,045333 0,918608 1,120533 15:00 1,091683 1,118708 1,084533 1,063483 0,968558 1,131733 
 15:20 1,053108 1,101708 1,057258 1,042058 0,912583 1,116633 15:20 1,089133 1,115583 1,081483 1,061033 0,962708 1,128983 
 15:40 1,050575 1,0977 1,053825 1,0388 0,9074 1,114725 15:40 1,0867 1,111625 1,078575 1,058 0,9572 1,12695 
 16:00 1,04695 1,09295 1,049925 1,0358 0,903 1,1133 16:00 1,0845 1,10825 1,07565 1,056 0,9526 1,125375 
 16:20 1,044983 1,089558 1,046783 1,032908 0,899283 1,109283 16:20 1,081883 1,104358 1,072333 1,053483 0,948208 1,122908 
 16:40 1,041275 1,08465 1,0428 1,02965 0,895125 1,10605 16:40 1,079175 1,1013 1,0695 1,051125 0,943475 1,1207 
 17:00 1,03955 1,081075 1,039525 1,026525 0,892325 1,1036 17:00 1,07685 1,097725 1,06635 1,04855 0,939575 1,11855 
 17:20 1,036167 1,077767 1,036167 1,023367 0,889967 1,101242 17:20 1,074217 1,094442 1,063492 1,046292 0,936042 1,116067 
 17:40 1,033867 1,074017 1,033267 1,020392 0,887692 1,098867 17:40 1,071242 1,090667 1,060442 1,043867 0,932917 1,114067 
 18:00 1,03085 1,070125 1,02955 1,017575 0,88505 1,095975 18:00 1,0689 1,0871 1,0574 1,04195 0,929675 1,111875 
 18:20 1,028425 1,066475 1,02655 1,01455 0,88365 1,093275 18:20 1,066675 1,084125 1,055175 1,0395 0,9274 1,109775 
 18:40 1,025275 1,0627 1,02315 1,01135 0,881125 1,0903 18:40 1,0637 1,080825 1,052225 1,037025 0,924325 1,1076 
 19:00 1,022025 1,059575 1,020075 1,009275 0,87955 1,08745 19:00 1,06185 1,079075 1,050825 1,035825 0,922475 1,106025 
 19:20 1,020192 1,055967 1,017117 1,006017 0,878042 1,084542 19:20 1,058617 1,074417 1,046917 1,032867 0,919842 1,103217 
 19:40 1,016908 1,052408 1,014158 1,003483 0,876033 1,082083 19:40 1,056083 1,071783 1,044958 1,031108 0,918033 1,101433 
 20:00 1,0143 1,049175 1,011475 1,000575 0,87465 1,079125 20:00 1,0537 1,068975 1,042675 1,0292 0,916 1,09915 
 20:20 1,011742 1,045817 1,009017 0,997917 0,873817 1,077067 20:20 1,050767 1,064667 1,039392 1,026317 0,913392 1,097692 
 20:40 1,009167 1,042642 1,006192 0,994717 0,871667 1,073967 20:40 1,047992 1,061492 1,036667 1,024142 0,911267 1,095592 
 21:00 1,006292 1,038767 1,003392 0,991542 0,870142 1,071167 21:00 1,044917 1,058542 1,034317 1,021842 0,909217 1,092967 
 21:20 1,003158 1,035683 1,000208 0,988608 0,868833 1,068033 21:20 1,042733 1,055958 1,032033 1,019533 0,907508 1,091208 
 21:40 1,000725 1,0329 0,997525 0,985475 0,868 1,065 21:40 1,03985 1,05345 1,02915 1,0172 0,905775 1,08895 
 22:00 0,99805 1,030175 0,994325 0,98255 0,866825 1,062125 22:00 1,03695 1,05075 1,026925 1,0152 0,904 1,086475 








Table O: Average raw data of four biological replicates from OD650 growth curve readings of double 
mutant TP+CIP strains with the respective WT strains (technical parallel 3 and 4) 
  Average TP+CIP parallel 3    Average TP+CIP parallel 4 
 Tim       CIP+TP22     CIP+TP 41 CIP+TP 78 WT 22          WT 41 WT 78                 Time      CIP+TP 22   CIP+TP 41   CIP+TP 78 WT 22         WT 41           WT 78 
 01:20 0,005975 0,00815 0,00895 0,00625 0,005075 0,008783  01:20 0,004825 0,00675 0,005975 0,0051 0,0049 0,008783 
 01:40 0,013308 0,017358 0,016883 0,011208 0,010733 0,019267  01:40 0,011033 0,015258 0,013033 0,010233 0,010708 0,019267 
 02:00 0,030525 0,038625 0,03505 0,02235 0,02315 0,043467  02:00 0,0254 0,034525 0,029325 0,02185 0,024 0,043467 
 02:20 0,06785 0,0835 0,0733 0,046 0,04985 0,096317  02:20 0,056475 0,075225 0,0624 0,045775 0,050575 0,096317 
 02:40 0,124758 0,141983 0,124483 0,092608 0,101783 0,16955  02:40 0,115783 0,130108 0,114508 0,092908 0,102433 0,16955 
 03:00 0,210775 0,2492 0,21325 0,149425 0,156025 0,289533  03:00 0,181 0,227175 0,188025 0,151 0,156275 0,289533 
 03:20 0,350175 0,411275 0,354625 0,256175 0,269725 0,458267  03:20 0,312625 0,3893 0,321675 0,258575 0,2696 0,458267 
 03:40 0,508908 0,571958 0,518708 0,409658 0,421508 0,61075  03:40 0,466958 0,558133 0,475908 0,412933 0,422583 0,61075 
 04:00 0,624308 0,672308 0,632258 0,546658 0,544733 0,71495  04:00 0,600258 0,652858 0,603683 0,547208 0,544133 0,71495 
 04:20 0,722508 0,765233 0,736608 0,651783 0,652933 0,813575  04:20 0,700808 0,754883 0,713933 0,654208 0,650908 0,813575 
 04:40 0,784725 0,825625 0,807675 0,7194 0,7202 0,881392  04:40 0,7721 0,815875 0,78955 0,723225 0,722325 0,881392 
 05:00 0,838783 0,879608 0,859733 0,774283 0,777683 0,937125  05:00 0,829658 0,871583 0,845658 0,777733 0,776983 0,937125 
 05:20 0,88225 0,915625 0,905775 0,824275 0,821975 0,984983  05:20 0,876325 0,910175 0,894125 0,828725 0,820675 0,984983 
 05:40 0,914117 0,942517 0,939142 0,870292 0,850742 1,026292  05:40 0,909767 0,939242 0,930242 0,874242 0,850242 1,026292 
 06:00 0,940608 0,966108 0,967658 0,915983 0,874958 1,0657  06:00 0,936608 0,964333 0,960983 0,921533 0,872333 1,0657 
 06:20 0,962075 0,98635 0,991525 0,95735 0,8896 1,095717  06:20 0,958475 0,9863 0,986725 0,961025 0,8881 1,095717 
 06:40 0,981117 1,005492 1,011092 0,990367 0,906817 1,118983  06:40 0,977842 1,006342 1,006592 0,994342 0,905717 1,118983 
 07:00 1,001933 1,024633 1,024658 1,017583 0,919408 1,138667  07:00 0,997133 1,027133 1,022183 1,020933 0,919533 1,138667 
 07:20 1,018508 1,036633 1,038358 1,039058 0,937033 1,153758  07:20 1,019658 1,039233 1,036708 1,043183 0,937633 1,153758 
 07:40 1,0335 1,050375 1,050175 1,058375 0,9548 1,164183  07:40 1,037825 1,05435 1,053625 1,066725 0,957425 1,164183 
 08:00 1,0404 1,0584 1,0568 1,0727 0,966575 1,170342  08:00 1,047575 1,064825 1,062725 1,082125 0,967475 1,170342 
 08:20 1,043075 1,05825 1,0582 1,08235 0,929875 1,1713  08:20 1,052 1,065675 1,066175 1,09075 0,930425 1,1713 
 08:40 1,040742 1,053142 1,056617 1,089342 0,902542 1,171425  08:40 1,051517 1,062142 1,066217 1,093067 0,905342 1,171425 
 09:00 1,036258 1,045258 1,053808 1,093008 0,889158 1,169858  09:00 1,047583 1,055983 1,064258 1,092558 0,891283 1,169858 
 09:20 1,03065 1,0378 1,0503 1,093725 0,88015 1,168717  09:20 1,042525 1,0487 1,06195 1,09165 0,8829 1,168717 
 09:40 1,023483 1,030858 1,046133 1,092833 0,873233 1,165117  09:40 1,035708 1,041908 1,058808 1,089983 0,876408 1,165117 
 10:00 1,017233 1,026608 1,040583 1,091058 0,866533 1,1626  10:00 1,030083 1,036633 1,055308 1,088558 0,870383 1,1626 
 10:20 1,011225 1,0215 1,0342 1,088525 0,85875 1,159142  10:20 1,024525 1,031025 1,050425 1,086525 0,8641 1,159142 
 10:40 1,005833 1,015358 1,028258 1,086083 0,851333 1,1556  10:40 1,019508 1,025658 1,044958 1,083983 0,857233 1,1556 
 11:00 1,000817 1,009392 1,021842 1,082542 0,843367 1,151967  11:00 1,013767 1,019817 1,040017 1,080542 0,850317 1,151967 
 11:20 0,995158 1,003883 1,017008 1,079308 0,836533 1,14975  11:20 1,008958 1,014608 1,034658 1,077983 0,844083 1,14975 
 11:40 0,989783 0,997808 1,011808 1,075783 0,830183 1,146408  11:40 1,004558 1,009808 1,030258 1,075508 0,838783 1,146408 
 12:00 0,984358 0,992308 1,007433 1,071933 0,823933 1,143958  12:00 0,999883 1,004383 1,026083 1,073133 0,834283 1,143958 
 12:20 0,979333 0,987333 1,002908 1,068183 0,817408 1,141025  12:20 0,994633 0,999833 1,021858 1,069908 0,828733 1,141025 
 12:40 0,974008 0,981858 0,998358 1,063958 0,809958 1,138933  12:40 0,990808 0,994983 1,018383 1,067458 0,823533 1,138933 
 13:00 0,968592 0,976567 0,994667 1,059967 0,802992 1,135925  13:00 0,985742 0,991567 1,014692 1,064192 0,817617 1,135925 
 13:20 0,965183 0,971608 0,990733 1,055558 0,797208 1,133592  13:20 0,981683 0,986708 1,011258 1,059958 0,812458 1,133592 
 13:40 0,960642 0,966942 0,987367 1,051642 0,792692 1,130108  13:40 0,977692 0,982842 1,008192 1,057117 0,808317 1,130108 
 14:00 0,956533 0,962108 0,984083 1,047508 0,788458 1,12745  14:00 0,974358 0,979183 1,005608 1,055283 0,803983 1,12745 
 14:20 0,952625 0,957425 0,980925 1,04365 0,785225 1,125892  14:20 0,97065 0,97575 1,0027 1,051525 0,800775 1,125892 
 14:40 0,948558 0,953133 0,977883 1,039633 0,782508 1,122875  14:40 0,967658 0,971558 1,000283 1,048658 0,797808 1,122875 
 15:00 0,945425 0,949175 0,97485 1,036775 0,780025 1,120533  15:00 0,9648 0,96845 0,9979 1,0463 0,795425 1,120533 
 15:20 0,942058 0,945508 0,971558 1,033508 0,776683 1,116633  15:20 0,962033 0,965408 0,995283 1,043733 0,793008 1,116633 
 15:40 0,938617 0,941742 0,968217 1,030517 0,772842 1,114725  15:40 0,959092 0,961917 0,992767 1,041142 0,790217 1,114725 
 16:00 0,935133 0,938108 0,965308 1,027583 0,769033 1,1133  16:00 0,956383 0,958983 0,990708 1,038758 0,787583 1,1133 
 16:20 0,931692 0,934792 0,962242 1,024917 0,766642 1,109283  16:20 0,953692 0,956617 0,988992 1,036967 0,785417 1,109283 
 16:40 0,928425 0,931525 0,95955 1,0226 0,764425 1,10605  16:40 0,95105 0,953475 0,986625 1,034725 0,7828 1,10605 
 17:00 0,925533 0,928908 0,956633 1,019683 0,763108 1,1036  17:00 0,948008 0,950833 0,984408 1,031933 0,780658 1,1036 
 17:20 0,922042 0,926067 0,954067 1,016817 0,761192 1,101242  17:20 0,945417 0,948142 0,982792 1,030317 0,778692 1,101242 
 17:40 0,919725 0,9238 0,9515 1,0148 0,7603 1,098867  17:40 0,94315 0,94585 0,98065 1,0282 0,777275 1,098867 
 18:00 0,917317 0,921842 0,948917 1,012292 0,759717 1,095975  18:00 0,940692 0,943617 0,978767 1,026342 0,775867 1,095975 
 18:20 0,913567 0,919017 0,946217 1,009692 0,757667 1,093275  18:20 0,937692 0,941442 0,976867 1,024592 0,774567 1,093275 
 18:40 0,910667 0,916892 0,943617 1,007117 0,756317 1,0903  18:40 0,935667 0,939617 0,974542 1,022717 0,773392 1,0903 
 19:00 0,908392 0,915292 0,941442 1,005042 0,755092 1,08745  19:00 0,933517 0,937917 0,972742 1,021242 0,771967 1,08745 
 19:20 0,905408 0,913383 0,939108 1,002733 0,754033 1,084542  19:20 0,930858 0,936108 0,970508 1,019858 0,771108 1,084542 
 19:40 0,903358 0,911708 0,937258 1,000308 0,752408 1,082083  19:40 0,929058 0,934908 0,968883 1,017808 0,769883 1,082083 
 20:00 0,901408 0,910783 0,934708 0,998383 0,751983 1,079125  20:00 0,927083 0,932833 0,966658 1,016133 0,768608 1,079125 
 20:20 0,898833 0,908908 0,932708 0,995808 0,751008 1,077067  20:20 0,923958 0,931058 0,964383 1,014083 0,767183 1,077067 
 20:40 0,895808 0,907133 0,930483 0,993358 0,749708 1,073967  20:40 0,922333 0,929933 0,962983 1,012833 0,766708 1,073967 
 21:00 0,89315 0,905625 0,928225 0,990675 0,748725 1,071167  21:00 0,91965 0,9287 0,9614 1,010875 0,765525 1,071167 
 21:20 0,890325 0,9044 0,92665 0,988425 0,74835 1,068033  21:20 0,917725 0,92735 0,95955 1,009225 0,7646 1,068033 
 21:40 0,88715 0,9031 0,92415 0,986025 0,7472 1,065  21:40 0,915425 0,925875 0,9578 1,007475 0,7636 1,065 
 22:00 0,885458 0,902308 0,923208 0,983908 0,747408 1,062125  22:00 0,913258 0,924558 0,956308 1,005783 0,762708 1,062125 







Appendix 4: Calculated relative generation time and significant differences 
Table P: The calculation of generation time in averages, standard deviations, standard errors and 95% 




WT22/TP2 WT41/TP4 WT78/TP4 
 2 1 1 P-value with the α set to 0,05 
 0,72 0,82758621 0,96428571 T-test 95% K.I. for TP22 
 0,76052632 1,07142857 0,96428571 0,00054145 
 0,75789474 0,96551724 1 
 0,78918919 1 0,96666667 T-test 95% K.I for TP41 
 0,75620915 0,96581197 0,97435897 0,582014 
St.dev 1,25830574 1,25830574 1,5 0,18929694 3,09569594 1,91485422 0,02839214 0,10235514 0,01749636  
st.error 0,62915287 0,62915287 0,75 0,09464847 1,54784797 0,95742711 0,01419607 0,05117757 0,00874818 T-test 95% K.I for TP78 
K.I 1,2331170 1,2331170 1,4699730 0,1855076 3,0337263 1,8765226 0,0278238 0,1003062 0,0171461 0,56135793 
Relative values 
WT22/CIP WT41/CIP WT78/CIP 
22 41 78 T-test 95% K.I for CIP22 
 0,96428571 1,07407407 1,11111111 0,43777289 
 1,03703704 1,18518519 1,07407407 
 0,90625 1,17857143 0,90322581 T-test 95% K.I for CIP41 
 0,9375 0,90909091 0,96774194 0,24246331 
 0,95798319 1,07826087 1,00862069 
st.dev 2,62995564 2,87228132 2,30940108 1,29099445 1,82574186 0,95742711 0,05580308 0,12889801 0,09565596 T-test 95% K.I for CIP78 
st.error 1,31497782 1,43614066 1,15470054 0,64549722 0,91287093 0,47871355 0,02790154 0,064449 0,04782798 0,85123317 
K.I 2,57730917 2,81478397 2,26317147 1,26515131 1,78919414 0,93826132 0,05468602 0,12631773 0,09374112  
Relative values 
WT22/TP+ WT41/TP+ WT78/TP+ 
CIP22 CIP41 CIP78 T-test 95% K.I for TP+CIP22 
 0,90909091 1,07142857 0,9 0,17848423 
 1 1,03333333 0,90967742 
 0,9 0,85185185 0,96206897 T-test 95% K.I for TP+CIP41 
 0,96551724 0,96551724 0,93 0,80545946 
 0,94262295 0,98245614 0,92479339 
st.dev 1,73205081 1,29099445 0,95742711 1,5 3,55902608 0,15 0,04744524 0,09632271 0,02743554 T-test 95% K.I for TP78 
st.error 0,8660254 0,64549722 0,47871355 0,75 1,77951304 0,075 0,02372262 0,04816135 0,01371777 0,01640604 
K.I 1,6973786 1,26515131 0,93826132 1,46997299 3,48778147 0,1469973 0,04649548 0,09439452 0,02688634  
 
 
N TP22 TP41 TP78  WT22 WT41 WT78 
1 40 29 28  28,8 24 27 
2 38 28 28  28,9 30 27 
3 38 29 31  28,8 28 31 
4 37 31 30  29,2 31 29 
Mean 38 29 29  28,9 28 29 
N CIP22 CIP41 CIP78 WT22 WT41 WT78 
1 28 27 27 27 29 30 
2 27 27 27 28 32 29 
3 32 28 31 29 33 28 
4 32 33 31 30 30 30 
Mean 30 29 29 29 31 29 
N TP+CIP22 TP+CIP41 TP+CIP78 WT22 WT41 WT78 
1 33 28 31 30 30 27,9 
2 30 30 31 30 31 28,2 
3 30 27 29 27 23 27,9 
4 29 29 30 28 28 27,9 





Appendix 5: Molecular weight standard: SmartLadder MW-1700-10 (Eurogentec) 
 
Figure C: Figure illustrating molecular marker (SmartLadder) used in gel electrophoresis. 
Information about this product can be found on producers’ web page:  
http://www.eurogentec.com/uploads/TDS-MW-1700-10.pdf 
 
 
 
 
 
 
